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Abstract
Concurrent with the well-documented motor speech production impairments in
amyotrophic lateral sclerosis (ALS), individuals with ALS exhibit language problems
including confrontation and generative naming difficulties, single word auditory and
reading comprehension problems, and decreased self-regulation based on fewer selfcorrected utterances, among other language disruptions. Health related quality of life
(HRQoL) measures specific to ALS often contain items related to its characteristic
speech production problems that are thought to influence overall quality of life.
However, the language problems in ALS are rarely if ever considered within the context
of HRQoL. The current study aimed to identify the relationship between language
problems (i.e., quality of communication) and HRQoL among individuals with ALS.
Twenty-eight participants with ALS completed a general HRQoL (i.e., SF-36) and a
quality of communication measure (i.e., ASHA QCL). Scores on these measures were
compared with standardized language test scores and discourse measures including
verbal fluency, the Boston Naming Test (BNT), and discourse measures obtained from
a picture description task. Participants also completed a cognitive status and depression
screening using the Montreal Cognitive Assessment (MoCA) and the Geriatric
Depression Scale (GDS), respectively. The severity of ALS was measured using the
ALS Functional Rating Scale. Results indicated that verbal fluency (animals), discourse
output, and speech intelligibility are associated with quality of communication.
Regression analyses revealed important predictors of quality of communication
including the BNT, MoCA, GDS, and speech intelligibility. The only significant predictor
for general HRQol (i.e., SF-36) was the GDS. Results suggest that poor performance
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on standardized language tests may not be indicative of poor quality of communication,
however, findings show that poor efficiency on discourse tasks does affect quality of
communication. Results also show that depression in individuals with ALS is associated
with poor HRQoL. Overall physical functioning does not significantly contribute to quality
of communication or overall HRQoL. An important implication of the findings is that
clinicians should focus on optimizing communication in those individuals with ALS who
have poor speech intelligibility in order to optimize discourse output, which, in turn, may
enhance the quality of communication in individuals with ALS.
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Introduction
ALS Background
Amyotrophic lateral sclerosis (ALS) is a motor neuron disease linked to cell death
of lower motor neurons (LMN) of the brainstem and spinal cord, and upper motor
neurons (UMN) of the cerebral cortex, leading to progressive paralysis of voluntary
muscles and ultimately death. The incidence rate of ALS in Canada is 2/100,000 (ALS
Society of Canada, 2008). Peak incidence rates occur between 50 and 70 years of age,
with men affected more than women at a ratio of 1.6:1.0 (Eisen & Krieger, 1993;
Mitchell & Borasio, 2007). Although ALS most often affects those older than 40 years of
age, 10% of cases involve patients younger than 40, and 5% of cases involve persons
younger than 30 years of age (Shoesmith & Strong, 2006). ALS is a fatal disease,
usually the result of respiratory failure where, following diagnosis, the mean length of
survival in ALS ranges from 2.4 to 4.1 years (Boman & Meurman, 1967; Mulder &
Howard, 1976). However, twenty percent of individuals with ALS survive longer than
five years and 10% survive longer than 10 years (Shoesmith & Strong, 2006). ALS is
considered the third most common adult-onset neurodegenerative disease (Strong,
Grace, Orange, & Leeper, 1996).
There are different types of ALS. Sporadic ALS is the most common type and
accounts for approximately 90% of ALS cases. In sporadic ALS, motor neurons
degenerate and die prematurely from unknown causes. Familial ALS occurs in roughly
10% of cases and usually results from an autosomal-dominant pattern of inheritance
(Mitchell & Borasio, 2007; Shoesmith & Strong, 2006). This inherited type of ALS
typically has a younger age of onset and men are not more likely to develop it
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(Mitsumoto, Chad, & Pioro, 1998). Other than fact of inheritance, the two prominent
types of ALS are clinically indistinguishable from one another (Mitsomoto et al., 1998).
According to the World Federation of Neurology (1994), individuals diagnosed
with ALS must show evidence of upper and lower motor neuron degeneration and
demonstrate that the signs have spread within a distinct region of the body. Individuals
diagnosed with ALS can first present with symptoms in the limbs, known as limb onset,
or in bulbar regions (e.g., speech or swallowing), known as bulbar onset. Shoesmith
and Strong (2006) reported that approximately 75% of individuals with sporadic ALS
present with limb-onset while approximately 21% present with bulbar onset. Individuals
with limb-onset ALS experience weakness in upper and/or lower extremities or truncal
muscles while individuals with bulbar-onset ALS initially report weakness and changes
in motor speech production and swallowing, known as dysarthria and dysphagia,
respectively (Mitsumoto et al., 1998). Bulbar ALS is localized within the corticobulbar
area of the brainstem in early stages of ALS and exhibits a faster progression than the
limb-onset form (Mitsumoto, 2009). Respiratory onset is an uncommon presenting
feature in ALS. However, the presence of impaired respiratory function is a negative
prognostic factor (Stambler, Charatan, & Cedarbaum, 1998).
Upper and lower motor neurons degenerate in both types of ALS (Mitsumoto et
al., 1998). Degeneration of the upper motor neurons results in muscle stiffness and
rigidity, hyperactive reflexes, and decreased ability to control laughing or crying.
Pseudobulbar palsy results from degeneration of upper motor neurons in bulbar regions
and in descending corticobulbar tracts (Mitsumoto et al., 1998). Pseudobulbar palsy
can result in exaggerated snout or jaw reflexes and spasticity of muscles, which cause
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slow repetitive movements of the tongue (Brockington, Ince, & Shaw, 2006).
Degeneration of the lower motor neurons results in muscle weakness and atrophy,
involuntary twitching of muscle fibers (fasciculations), muscle cramps, decrease in
muscle tone, weakened reflexes, difficulty swallowing (dysphagia), shortness of breath
at rest (dyspnea), and difficulty speaking (dysarthria) (Brockington et al., 2006). Lower
motor neuron involvement results in flaccid or paretic bulbar palsy, in which there is
wasting of the tongue musculature, a flaccid tone, and fasciculations (Darley, Aronson,
& Brown, 1975; Mitsumoto et al., 1998).
Weight loss due to amyotrophy, nutritional deficiencies and dysphagia are
common clinical features in ALS. As well, individuals experience head drop, due to
weakening of the neck muscles. They also experience dyspnea and orthopnea, due to
weakening of the respiratory muscles; and symptoms that result from nocturnal carbon
dioxide retention (e.g., morning headache, anorexia, and daytime somnolence)
(Mitsumoto et al., 1998).
Speech Production in ALS
Speech production in individuals with ALS can eventually becomes unintelligible
as a result of the progressive degeneration of the oral, velopharyngeal, and laryngeal
articulators (Bonduelle, 1975). Individuals with ALS exhibit speech difficulties
characterized as mixed flaccid-spastic dysarthria as a result of both upper and lower
motor neuron degeneration (Darley et al.,1975). Speech production in these individuals
is characterized by imprecise consonants, hypernasality, harsh voice quality, slow
speaking rate, monopitch, and short phrases. These characteristics manifest slightly
differently in each individual and occur at different times throughout disease progression
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(Renout, Leeper, Bandur, & Hudson, 1995). The progression of dysarthria leading to
anarthria (inability to speak) contributes to communication difficulties in individuals with
ALS (Darley, Aronson, & Brown, 1975). In addition to dysarthria, communication in ALS
also is affected by problems in cognition and language (Strong et al., 1999).
Cognition in ALS
The neural degeneration associated with ALS was once considered restricted to
large motor neurons leaving cognition intact. However, it is now widely accepted that
cognitive impairment exists in ALS, wherein it is classified as a multi-systems disorder
with a wide range of cognitive problems (Strong et al., 1999). The cognitive profile of
individuals with ALS ranges along a continuum from no discernable cognitive deficits to
severe dementia meeting diagnostic criteria for frontotemporal dementia (FTD)
(Loemen-Hoerth et al., 2003; Neary et al., 1998). Cognitive impairment (CI) in the
absence of dementia is now recognized as a robust finding in individuals with ALS (Abe
et al., 1997; Abrahams et al., 1997; Bak & Hodges, 1999; Gallassi et al., 1985; Gordon,
et al., 2010; Hanagasi et al., 2002; Kilani et al, 2004; Lomen-Hoerth, et al., 2003;
Raaphorst, DeVisser, Linssen, DeHaan, & Schmand, 2010; Strong et al.,1999). The
prevalence of CI in ALS sample populations is estimated to range from 35.6% to 50%
(Massman, Sims, Cooke, Haverkamp, & Appel, 1996; Phukan et al., 2012; Ringholz et
al., 2005). In a population based study of 160 individuals with ALS, Phukan et al.
(2012) found that 47% of individuals showed no discernable cognitive deficits, 21%
exhibited a cognitive impairment including executive dysfunction, 14% possessed a
cognitive impairment with no executive dysfunction (i.e., showed language or memory
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deficits), 14% demonstrated ALS-FTD, and the remaining 4% displayed coinciding
Alzheimer’s dementia or were unable to be categorized.
The typical profile of CI in ALS includes disruptions to attention systems and
processes, executive dysfunction, problems with multiple memory systems, and
impaired visuospatial skills. Deficits also manifest as declines in verbal and non-verbal
fluency, working memory, cognitive flexibility, sustained attention, recognition memory
for words and faces, visual perception, reasoning, word generation, word fluency, and
executive functions such as planning, organizing, and self-monitoring (Abe et al., 1997;
Abrahams et al., 2000; Elamin et al., 2011; Portet, Cadilhac, Touchon, & Camu, 2001;
Strong et al., 1996; Strong et al., 1999, Talbot et al., 1995). Portet et al. (2001) found
that ALS disease severity was more pronounced when cognitive impairment was
present. Cognitive impairments in ALS are associated with shorter survival times
(Elamin et al., 2011; Gordon et al., 2010).
Whereas in some individuals with ALS cognitive dysfunction is undoubtedly due
to the degenerative process associated with the disease, others exhibit cognitive
dysfunction that is related to respiratory compromise. Cognitive status in persons with
ALS has been correlated with reduced vital capacity. Kim et al. (2007) found that
participants with a reduced vital capacity performed significantly poorer in memory
retention, retrieval efficacy, and spoken verbal fluency than those participants with a
normal vital capacity. Individuals with ALS showed improved cognition as a result of
using non-invasive positive pressure ventilation over six weeks (Newsom-Davis, Lyall, &
Leigh, 2001). The cognitive status is likely due to neuronal loss, gliosis, or sponginess
in the hippocampus and parahippocampal regions that are vulnerable to hypoxia (Kato,
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Oda, & Hayashi, 1994). Respiratory insufficiency can be identified using values of vital
capacity, nasal inspiratory pressure, oxygen saturation, diaphragmatic amplitude, or
blood gas levels (Hardiman, 2011). Low carbon dioxide-blood gas levels measured noninvasively in arterialized venous blood using a transcutaneous earlobe monitor are
considered the “gold standard” of respiratory insufficiency (Hardiman, 2011).
In addition to respiratory compromises affecting cognition in ALS, there is a large
body of evidence showing that depression affects cognition. For example, Lichetenburg,
Ross, Millis, and Manning (1995) found a modest relationship between scores of 220
older adults on the Geriatric Depression Scale (GDS) and two measures of cognition;
the Dementia Rating Scale (DRS) and the Logical Memory Test. The GDS scores were
a consistently significant predictor of the DRS and Logical Memory scores. The authors
concluded that depression is an independent predictor of cognition. Depression also
can frequently be associated with executive deficits, which in turn, can influence
participants’ performances in high-level language processing or verbal fluency tasks,
which are largely dependent on executive functions (Starkstein, Bolduc, Mayberg,
Preziosi, & Robinson, 1990). Prevalence rates for depression in individuals with ALS
range from 0% to 44%, but studies using the structured interview according to DSM-IV
criteria for depression find highly consistent rates of 9 to 11% (Kurt, Nijboer, Matuz, &
Kubler, 2007). More recently, McElhiney, Rabkin, Gordon, Goetz, and Mitsumoto
(2012) found that, in a sample of 223 individuals with ALS, only 7% (16/223) had major
or minor depression and that the depression was not associated with ALS severity. It is
prudent to take into account the presence of depressive symptoms when evaluating
language abilities in individuals with ALS.
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A diagnosis of dementia requires multiple cognitive deficits of gradual onset and
continual decline, which include both memory and any one or more of the following:
language problems, movement programming problems, agnosia, or disturbance in
executive functioning (DSM –IV TR, 2000). These impairments must cause significant
impairment in social or occupational functioning and must represent significant decline
from previous functioning. In addition, deficits cannot be caused by other central
nervous system (CNS) conditions, systemic conditions known to cause dementia,
substance abuse, delirium, or any other primary psychiatric disorder (DSM IV-TR,
2000).
Frontotemporal-type dementia (FTD) is the most common type of dementia in
ALS (Bak & Hodges, 1999). FTD is defined as a behavioural syndrome marked by
profound alternations in personality and social conduct, inertia and loss of volition or
social disinhibition, with a relative preservation of memory (Neary et al., 1990). The
term FTD is restricted to the overall clinical spectrum of frontotemporal dementia
including behavioural variant FTD (bvFTD), and three variants of primary progressive
aphasia (PPA). The term frontotemporal lobar degeneration (FTLD) is restricted to the
neuropathological correlate of FTD (Strong, 2008).
Symptoms of FTD include disinhibition, impulsivity, changes in sleep and eating
patterns, decreased attention, decreased executive functioning and planning, apathy,
and poverty of speech production and spoken language progressing to mutism (Neary
et al., 1990). ALS-frontotemporal dementia (ALS-FTD) is estimated to occur in three
percent of sporadic cases and 15% of the familial type (Bak & Hodges, 1999; Loemen-
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Hoerth et al., 2003). ALS-FTD is a negative prognostic indicator including shortened
disease duration with more severe symptom presentation (Elamin et al., 2011).
Any variant of FTD can be associated with ALS, however, the behavioural variant
FTD (bvFTD) and nonfluent variant primary progressive aphasia (nfvPPA) are most
commonly associated with ALS, because they are localized to the frontal lobes of the
cortex near the motor strip. Individuals with ALS can display signs and symptoms of
each variant of PPA that occur within the clinical syndrome of FTD; nfvPPA, semantic
variant PPA (svPPA), or logopenic variant PPA (lvPPA). nfvPPA is sometimes the first
clinical diagnosis in those who develop ALS-FTD (Bak, O’Donovan, Xuereb, Boniface, &
Hodges, 2001; Lomen-Hoerth et al., 2003; Strong, 2008). Although language deficits
are common in ALS, it is debatable whether these deficits are strictly language
impairments or part of an underlying cognitive impairment (South, Findlater, Strong, &
Orange, 2012).
Language in ALS
Individuals with ALS exhibit language impairments in the absence of CI or FTD.
The language performances of individuals with ALS have been studied in combination
with other neuropsychological batteries as part of general cognitive testing in ALS
(Cobble, 1998). Language deficits of individuals with ALS without CI or FTD most
commonly include word retrieval problems (Abrahams et al., 2004; Abrahams, Leigh, &
Goldstein, 2005; Mantovan et al., 2003; Racowicz & Hodges, 1998; South, Findlater,
Strong, & Orange, 2011; Strong et al., 1999). Naming deficits occur in both category
verbal fluency tasks (e.g., naming animals) and letter verbal fluency tasks (e.g., naming
words that begin with the letter “F”) (Abrahams et al., 2000; Hanagasi et al., 2002;
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Strong et al., 1999) along with problems in confrontation naming (Abrahams et al.,
2004; Hanagasi et al., 2002; Mantovan et al., 2003; Ringholz et al., 2005; Strong et al.,
1999). Reduced single-word vocabulary comprehension (Strong et al., 1999), impaired
auditory comprehension (Mantovan et al., 2003), and verbal and semantic paraphasias
on confrontation and noun naming tasks (Cooper et al., 2008; Strong et al., 1999) also
are overall common features of the language profile of individuals with ALS. Abrahams
et al. (2005) found impairments in both spoken and written verbal fluency tasks in ALS
participants without dementia. However, the verbal fluency did not change over time.
This suggests that verbal fluency impairments in ALS may result from higher order
cognitive dysfunction, indicating deficits in attention systems or central executive
component of working memory (Abrahams et al., 2004). It is important to note that
among normal individuals, it is not until they are generally over the age of 75 that they
experience word retrieval problems and difficulties on confrontation and generative
naming tasks associated with aging (Goodglass, 1980; Nicholas, Barth, Obler, Au, &
Albert, 1997). Executive functioning (i.e., planning, organizing, and reasoning) and
episodic memory also are affected by aging. Typically, recall of information is affected
more than the ability to recognize previously seen or heard information (Nyberg et al.,
2003).
Individuals with ALS without CI or without FTD demonstrate decreased selfregulation with fewer self-corrected utterances during discourse (South et al., 2011;
Strong et al., 1999). Narasimha (2009) also showed that individuals with ALS without
CI or without FTD produce more simplified verb structures, as well as more
parenthetical remarks, suggesting possible word retrieval or language deficits. Using
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the same discourse measures, South et al. (2011) showed differences in word finding
indices of word retrieval in individuals with ALS compared to controls. Reduced
discourse efficiency in the South et al. (2011) study was hypothesized to be due to
presence of revisions and reformulations (i.e., “[He is] [she is climbing] she was
reaching for a cookie,”) or to the presence of “empty words” which do not enhance the
content (e. g. “The [thing] it is somewhat a [you know thing]”). Word retrieval problems
may underscore the reduced discourse efficiency seen at all time points in the study.
Strong et al. (1999) also tested communication during discourse in ALS using a topicdirected interview (TDI) protocol, based on Ripich and Terrell (1988), at two times
periods over six months. Results indicated that individuals with ALS produced
significantly fewer self-corrected utterances than did controls at the six-month period.
Two longitudinal studies addressed the progression of language impairment
without dementia throughout the course of ALS (Abrahams et al., 2005; Strong et al.,
1996). In both studies, participants were tested at baseline and again six months later.
Strong and colleagues (1996) did not find any significant differences in the language
performances of their participants over time. Abrahams and colleagues (2005),
however, found evidence of significantly slower word retrieval times for the participants
with ALS on the Computerised Sentence Completion test at the six-month follow up
period.
Structural and functional brain imaging changes correlate strongly with cognitive
and language impairments in individuals with ALS (Abrahams et al., 2004; Bak &
Hodges, 2004; Kew et al., 1993). Cognitive and language impairments may be
secondary to neuronal loss in the cortex throughout disease progression. Using PET
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imaging, Abrahams et al. (1997) reported that individuals with ALS who exhibited
deficits in verbal fluency demonstrated cortical and subcortical dysfunction. These
deficits affected the frontal lobes with extension into the insular cortex and thalamic
nuclei. Abrahams et al. (2004) studied letter fluency, category fluency, and picture
confrontation naming in 28 ALS participants and 18 controls in conjunction with fMRI.
The letter fluency task was associated with reduced activation in extensive regions of
the left prefrontal cortex, left temporal lobe, left parietal lobe, and right anterior cingulate
gyrus. Increased activation was found in the right inferior frontal gyrus, right middle
temporal gyrus, and left superior frontal gyrus. During the confrontation-naming task,
there was impaired activation in the left prefrontal cortex, right inferior frontal gyrus, right
cingulated gyrus, left temporal lobes, bilateral parietal lobes, and occipital lobes.
Although language deficits in ALS are evident, it is unclear whether these deficits are
part of an underlying cognitive impairment or strictly linguistic in nature (South et al.,
2011). Recent evidence suggests that executive dysfunction impairments do not
underscore the language problems in ALS (Taylor et al., 2012). Language impairments
in individuals with ALS without CI or without dementia may be an under recognized
feature of ALS and can progress over time.
Individuals with ALS-FTD display various language impairments (Hayley &
Ramer, 2000). These include impaired comprehension for both complex sentences and
single word semantic processing tasks, as well as reading and writing difficulties
(Caselli, et al., 1993; Cobble, 1998; Hayley & Ramer, 2000; Rakowicz & Hodges, 1998).
ALS-FTD affects word retrieval, language comprehension, and spelling (Bak & Hodges,
1997, 2004; Neary et al., 1990; Rakowicz & Hodges, 1998). Individuals with ALS-FTD
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ranged from normal, to mildly impaired to echolalic on tests of verbal repetition
(Cavelleri & DeRenzi, 1994; Neary, et al., 1990). Impairments also are prominent for
nouns and verbs on both naming and comprehension tasks, with increased difficulty for
verbs (Bak & Hodges, 1997, 2004; Hillis, Oh, & Ken, 2004). Bak and Hodges (2004)
reported that language deficits might be an early and prominent feature of individuals
with ALS-FTD.
Quality of Life (QoL) in ALS
The World Health Organization (1994) defines QoL as, “the individual’s
perception of their [sic] position in life in the context of culture and value systems in
which they [sic] live and in relation to their [sic] goals, expectations, standards and
concerns” (p. 1). “QoL is a broad ranging concept affected in a complex way by the
persons’ physical health, psychological state, level of independence, social relationships
and their relationship to salient features in their environment” (WHO, p.1). QoL is
determined by considering heath-related factors (physical, functional, emotional, and
mental-wellbeing) and non-health-related factors (jobs, family friends, spirituality, and
other life circumstances) (Burns, Graham, Rose, & Simmons, 2012).
Physical status has been shown to be less relevant in determining overall QoL in
ALS, wherein QoL remains stable while physical function declines (Chio et al., 2004;
Lulé, Häcker, Ludolph, Birbaumer, & Kübler, 2008; Nygren & Askmark, 2006; Robbins,
Simmons, Bremer, Robbins, Walsh, & Fisher, 2001). Tramonti, Bongioanni, Di
Bernardo, Davitti, and Rossi (2012) found that participants’ self-perceived quality of life,
measured by the Schedule for the Evaluation of Individual Quality of Life Direct
Weighting Scale (SEIQoL-DW), was not correlated with any scores of physical
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functioning or depression, confirming previous findings emphasizing how the subjective
perception of life satisfaction is not necessarily related to physical functioning and even
to HRQoL. The Amyotrophic Lateral Sclerosis Functional Rating Scale (ALS-FRS), a
measure of disease severity, score is not a predictor of QoL. However, depression
severity is correlated with lower QoL scores in those with ALS (Krampe et al., 2008).
The QoL of 26 individuals with ALS, as assessed by participants’ responses to the
McMaster QoL (Sterkenburg, King, & Woodward, 1996) scale every four to seven
months did not change significantly over a 24-month follow up period (Nygren &
Askmark, 2006). Using the same QoL scale, Roach, Averill, Segerstrom, and Kasarski
(2009) found that the effect of time did not affect the QoL of individuals with ALS.
However, the total QoL, and in particular QoL related to physical symptoms of
individuals with ALS, declined over time for their caregivers. Lule et al. (2008) did not
find any correlation between physical disability in ALS and either depression or selfperceived QoL (SEIQoL-DW). The severity of depression in this study was inversely
related to educational status, and QoL of these individuals with ALS was comparable to
healthy controls. Individuals with ALS experienced a satisfactory QoL without
depressive manifestations even if they were severely physically impaired, including
those who were in the terminal phases of the disease.
Goldstein, Atkins, and Leigh (2002) found that global self-ratings of individuals
with ALS, measured by the SEIQoL-DW (O’Boyle, 1994), were correlated positively with
scores on a self-report measure of cognitive functioning called the Short Inventory of
Mental Lapses (SIML). In this instance, greater self-rated cognitive impairment was
related to poorer perceptions of QoL. The authors noted, however, that with more
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cognitive impairment, the use of the SEIQoL-DW might be invalidated. since its
completion requires the participant to have insight, to think about abstract concepts, to
make judgments, and to use visual analogue scales. The investigators also found that
there is no correlation between SEIQoL-DW scores and any of the measures of physical
or functional status as measured by the ALS Severity Score (ALSSS) or the Sickness
Impact Profile (SIP). Anxiety or depression scores were not significantly correlated with
SEIQoL-DW scores, indicating that mood did not influence self-perceived QoL scores.
The researchers concluded that cognitive functioning also should be considered when
evaluating QoL in ALS.
The presence of neurobehavioural symptoms associated with ALS-FTD
correlates significantly with lower caregivers’ QoL, higher caregiver depression, and
higher caregiver burden, which can have profound impacts on caregivers’ emotional
status (Chio, et al., 2010). A low level of QoL in participants with ALS is thought to be
due to pre-existing individual differences, whereas age and disease progression are
likely to affect QoL among ALS caregivers (Roach et al., 2009). Grehl, Rupp, Budde,
Tegenthoff, and Fangerau (2011) found that self-ratings of QoL by individuals with ALS
vs. their relatives perceived ratings of QoL for their relative with ALS are not statistically
different using the Munish Quality of Life Dimensions List (MLDL) (von Steinbüchel,
Bullinger, & Kirchberger, 1999).
More research has been completed in HRQoL and other neurodegenerative
diseases. In a study of individuals with Parkinson’s disease (PD), Schrag, Jahanshahi
and Quinn (2000) found that the spheres of daily living that deteriorated with advancing
disease are associated predominately with mobility, self-care, activities of daily living,
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physical and social functioning on generic measures of QoL such as the SF-36 (Ware &
Sherbourne, 1992) and the EuroQoL (The EuroQoL Group, 1990). However, when
participants with PD completed a disease-specific QoL measure, the PDQ-39
(Jenkinson & Fitzpatrick, 2007), cognition, communication, and bodily discomfort lower
QoL scores significantly. Ross and Wertz (2003) found that individuals with chronic
aphasia could be distinguished from persons who do not exhibit aphasia based on
different facets of QoL. These facets include level of independence, social relationships,
and environment. Ross and Wertz (2003) suggested that, to enhance QoL in
individuals with language impairments such as those with chronic aphasia, therapy
should focus on situation-specific communication and societal participation. Although
individuals with PD and aphasia do not exhibit the same communication difficulties as
individuals with ALS, some of the features of these diseases are similar to features in
ALS.
Health Related Quality of Life (HRQoL) in ALS
HRQoL is defined as, “the value assigned to the duration of life as modified by
social opportunities, perceptions, functional states and impairments that are influenced
by disease, injury, treatment, or policy and should include some assessment of general
wellbeing and satisfactions with treatment, outcome, and health status with future
prospects” (O’Boyle & Waldron, 1997, p. 3). HRQoL is a more narrow term than QoL,
although the terms have been used interchangeably, on occasion, in the literature.
HRQoL often is viewed from more of a medical perspective, and so it often does not
include factors such as family, support systems, religiosity, or income, unless these
domains are directly affected by the health status of the individual. HRQoL differs from
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QoL in that it addresses issues that are related to the presence of disease or to the
treatment of disease (Burns et al., 2012). The devastating physical and emotional
effects of ALS have detrimental impacts on the HRQoL of those with ALS as well as on
the HRQoL of caregivers, family, and friends.
It has become increasingly important to use HRQoL measures to assess the
improvement of health care services and to incorporate patient based outcomes to
provide patient-centered baseline for assessment and treatment of various health
conditions (Mitsumoto & Del Bene, 2000). For example, scores on the ALS-specific
HRQoL scale (SIP/ALS-19), which are primarily based on physical function, decline in
parallel with scores on the ALS-Functional Rating Scale (ALS-FRS), a disease severity
measure (Robbins et al., 2001). Tramonti, et al. (2012) also found an overlap in the
domain of physical functioning when comparing scores on the physical functioning
subscale of the SF-36 and the ALSFRS-R. Kiebert et al. (2001) asked individuals with
ALS who were at different stages of the disease to complete a visual analogue scale of
their own health rating and to complete a ALS-specific health status measure (ALSAQ40) (Jenkinson, Brennan, Fitzpatrick, Bromberg, & Swash, 1999) to measure HRQoL.
They found that HRQoL decreases systematically with disease severity. Olsson
Oazanne, Strang, and Persson (2011) compared the scores from individuals with ALS
and their next of kin on the Short-Form 36 (SF-36) a general HRQoL measure vs. the
scores from a subset of a general Swedish population. A strong correlation was found
in both the mental component summary in SF-36 and in scores related to anxiety
between the groups of participants and their next of kin. There were no significant
correlations for the physical component summary scores or the depression scores
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between the groups of participants and their next of kin. Findings showed that the
HRQoL socres are not related to the physical function of the participants with ALS. Both
individuals with ALS and their next of kin exhibited some poorer ratings on the SF-36
and on measures of anxiety and of depression than did those from the general Swedish
population. Gender or age did not affect the estimates in any of the scales. Chio et al.
(2004) concluded that HRQoL measures may not be adequate to assess overall QoL in
ALS because QoL in ALS depends on psychological, supportive, and spiritual factors.
Interestingly, although HRQoL in individuals with ALS declines over time, self-rated
global QoL, does not appear to do so (Burns et al., 2012).
QoL and HRQoL are difficult concepts to measure, especially among individuals
with ALS. Some of the QoL and HRQoL measures are disease specific while others are
generic and not disease specific in nature. A disease-specific vs. a general measure of
the quality of life, and vice-versa, will be appropriate depending on the purpose and the
objectives of the study (Burns et al., 2012).
Statement of the Problem
Health care providers can underestimate the QoL and HRQoL of individuals with
chronic diseases and often can make assumptions about the importance of strength
and physical ability (Olsson et al., 2010). Many of the scales used to evaluate QoL and
HRQoL in ALS are generic in nature and items therein often are not specific to the
disease per se (Bromberg & Forshew, 2001). Moreover, there are few disease specific
QoL and HRQoL measures for persons with ALS and none that contain items that
address communication problems; problems that are now well recognized in published
studies on the cognitive and language impairments in ALS (Paul et al., 2004).
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The determinants of HRQoL in ALS are unclear. The relationship between
HRQoL and communication impairments in ALS needs to be explored, where current
evidence shows that psychological and social issues in ALS affect HRQoL more
severely than do physical symptoms alone. The communication of individuals with ALS
is impaired in both the severity of their dysarthria and their language and cognitivecommunication deficits. The impact of language deficits on quality of communication in
those with ALS remains to be explored. It is expected that individuals with ALS who
exhibit language or cognitive impairments will display lower HRQoL than individuals with
ALS who are not affected by any language or cognitive deficits.
Objectives
The objective of this study is to determine whether language and speech
intelligibility impairments in individuals with ALS are associated with poor self-perceived
quality of communication and overall HRQoL.
Research Questions
The following research questions are posed for this study. They are:
RQ 1 Language and Quality of Life Measures
What is the association between language scores on the Boston Naming Test (Kaplan,
Goodglass, & Weintraub, 1983), verbal fluency (i.e., animals), and measures of
language output from the Cookie Theft description task (Boston Diagnostic Aphasia
Examination – BDAE – 3rd edition) (Goodglass, Kaplan, & Baressi, 2001) and:
a) Self-Rated Quality of Communication (ASHA QCL measure) (Paul et al.,
2004)?
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b) Self-Rated Health Related Quality of Life (SF-36 measure) (Ware &
Sherbourne, 1992)?
RQ 2 Speech Intelligibility and Quality of Life Measures
What is the correlation between perceived speech intelligibility ratings and:
a) Self-Rated Quality of Communication (ASHA QCL measure) (Paul et al.,
2004)?
b) Self-Rated Health Related Quality of Life (SF-36 measure) (Ware &
Sherbourne, 1992)?
RQ 3 Speech Intelligibility and Language Measures
What is the correlation between perceived speech intelligibility ratings and language
scores on the BNT, verbal fluency (animals), and measures of language output from the
Cookie Theft description task?
RQ 4 Predictors
What are the relative contributions of the BNT, MoCA, GDS, speech intelligibility, and
the ALSFRS-R to:
a) Self-Rated Quality of Communication (ASHA QCL) (Paul et al., 2004)?
b) Self-Rated Health Related Quality of Life (SF-36) (Ware & Sherbourne, 1992)?
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Method
Participants
Twenty-eight participants with a diagnosis of probable or definite ALS defined by
the El Escorial diagnostic criteria (1995) for ALS were recruited as a convenience
sample from the London Health Sciences Centre (LHSC) Motor Neuron Disease Clinic
at University Hospital in London, Ontario led by neurologist Dr. Christen Shoesmith
(CS). All participants were between 38 to 74 years of age with a mean of 59.25 years
(+/- 9.62 SD), and spoke and understood English as their first language. All 28
participants self-reported normal and functional vision and hearing. Participants were
excluded if they had a history of other neurologic or psychiatric conditions that affect
cognition and language performance (e.g., major hemispheric stroke, traumatic brain
injury, learning disability, epilepsy, alcohol dependence syndrome, severe mental
illness, use of high-dose psychoactive medication, or evidence of FTD according to
Neary et al. (1998) criteria and Strong et al. (2009) criteria. Participants were not
excluded based on cognitive or depression screening, and instead cognition and
depression scores were factored into the analyses. It was thought that not enough
participants in the MND clinic would be eligible to participate in this study if such strict
exclusion criteria were used. Participants also were excluded if they exhibited a PCO2
level greater than 50 mmHg within three months of participation, as determined by chart
review. Table 1 displays the demographic characteristics of the participants with ALS.
No controls were used in this study.
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Table 1
Demographics of participants with ALS (N=28)
Characteristics and Tests
Mean
SD
Range
Age (yrs)
59.3
9.61
43-74
Education (yrs)
14.2
2.7
7-19
Handedness (27 R: 1 L)
Gender (17 Men: 11 Women)
MoCA (max 30)
24.6
3.4
16-30
GDS (max 30)
7.8
4.8
2-22
ALSFRS-R (max 48)
30.9
9.7
14-45
Speech subtest (max 4)
2.7
1.0
1-4
Note. MoCA = Montreal Cognitive Assessment, GDS = Geriatric
Depression Scale, ALSFRS-R = ALS-Functional Rating Scale Revised
Procedure
This study of individuals with ALS was a cross-sectional in design. All testing
was video and audio digitally recorded using a Canon™ VIXIA HFM500 video camera
and a Rode™ Videomic Pro Compact Shotgun Microphone. Data were collected in one
session lasting approximately 1.5 hours. Data were collected in the research room of
the Motor Neuron Diseases unit on the seventh floor at the LHSC-UH site (n=15) or in
participants’ homes (n=13). Data were collected by the author (KMF) and her research
supervisor (JBO) (n=19) or by the author herself (n=9). Written consent was obtained
from each participant. This study was authorized by the Office of Research Ethics at
Western University (HSREB code #102807). A Data Transfer Agreement with Lawson
Health Research Institute was also granted for this study (See Appendix A for the Letter
of Information, Letter of Consent, HSREB authorization form, Lawson Health Institute
Approval, and Data Transfer Agreement).
ALS participants first completed the Cookie Theft picture description task from
the Boston Diagnostic Aphasia Examination – 3rd Edition (Goodglass, Kaplan & Baressi,
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2001) to obtain a language sample suitable to calculate measures of correct content
units and measures of content efficiency. The purpose of collecting these measures
was to obtain a sample that was representative of each participant’s spontaneous
discourse output given the same picture to describe.
Productivity measures for the language samples included total words, total
utterances, and mean length of utterance (MLU). Words were defined according to the
criteria described by Nicholas and Brookshire (1993), including intelligible words within
context but which are not required to be accurate, relevant, or informative relative to the
topic being discussed. For example, filler words such as, “you know”, “I mean” or
interjections such as “oh, wow, golly, gosh, and gee” were counted. Words or partial
words that were intelligible in context such as, “The moth mother,” for example, were
not counted. Non-filler words, such as, “um, er, uh, hmm, and mmm,” were not
counted. Utterances were defined as a group of words expressing a complete thought
separated from other utterances based on content shifts, intonation changes, and/or
pauses (Shewan, 1988). Mean length of utterance was defined as described in
Retherford (1993).
Discourse measures of content including Correct Information Units (CIUs) were
defined using the definition of Nicholas and Brookshire (1993). CIUs were defined as
those words that were intelligible in context, accurate to picture/topic content, and
relevant to picture/topic content. The number of different novel concepts used to
describe the picture was determined using content units (CUs), based on the method
reported by Yorkston and Beukelman (1980). CUs reflect participants’ abilities to
deduce information from the Cookie Theft picture. A second content efficiency measure
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was calculated by dividing the number of CU by the total number of words to generate
the measure of words per CU. None of the 28 participants were anarthric, as each
participant was able to complete the task verbally.
After the discourse sample was obtained, the content was transcribed
orthographically and segmented into utterances by the author (KMF) and a trained but
naïve assistant (undergraduate student) who did not know the purpose of the study.
Reliability scores for words for intra- (all samples) and inter-transcriber agreement
studies (5 transcripts = 17.8% of transcripts for the naïve transcriber) were calculated
using Cronbach’s alpha and were (α = .999) and (α = .997), respectively. Reliability
scores for utterance segmentation for intra- (all samples) and inter-transcriber
agreement studies (5 transcripts = 17.8% of transcripts for the naïve transcriber) were
calculated using Cronbach’s alpha and were (α = .997) and (α = .995), respectively.
Reliability scores for correct information units for intra- (all samples) and intertranscriber agreement studies (5 transcripts = 17.8% of transcripts for the naïve
transcriber) were calculated using Cronbach’s alpha and were (α = .998) and (α = .898),
respectively. Reliability scores for Content Units for intra- (all samples) and intertranscriber agreement studies (5 transcripts = 17.8% of transcripts for the naïve
transcriber) were calculated using Cronbach’s alpha and were (α = .997) and (α = .982),
respectively.
Participants with ALS also completed standardized language tests including a
30-item short-version of Boston Naming Test (BNT) (Kaplan et al.,1983). The BNT is a
60-item test in which participants are shown black-line drawings of nouns and are asked
to name those nouns. The purpose of using the BNT in this study was to assess
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participants’ abilities on confrontation noun naming, which can be impaired in ALS.
Participants also completed seven measures of verbal fluency, including four categories
of living items (i.e., animals, breeds of birds, breed of dogs, and water creatures) and
three categories of non-living items (i.e., methods of transportation, musical
instruments, and tools). These categories are based on an adapted version of the
Hodges, Salmon, and Butters (1992) category fluency task conducted with individuals
with Alzheimer’s disease. All participants with ALS were asked to generate verbally as
many items as they could in one minute for each of the seven categories. One
participant was allowed to respond in written form due to severe motor speech
impairment. An additional 30 seconds was provided to the participant for the first
category (animals). In the first 60-second period of the animals category she produced
a normal number of exemplars and did not write any additional exemplars in the extra
30 seconds that were provided. Given her performance on this category, it was decided
that she did not need additional time to complete the written task. She was allowed 60
seconds for each remaining category. The purpose of the verbal fluency task was to
assess participant’s ability in generative noun naming when given a category, which has
been shown to be impaired in most individuals with ALS.
Participants with ALS then completed the Geriatric Depression Screening Scale
(GDS), a 30-item, self-rated depression scale specifically designed for identifying and
rating depression in older adults (Yesavage & Brink, 1983). The GDS is reliable and
valid in rating depression among adults with and without dementia (Stiles &
McGarrahan, 1998). The GDS questions are answered using "Yes" or "No" responses.
The binomial response option enables those who are ill or who suffer a mild or
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moderate cognitive impairment to complete the measure with relative ease. The scale
is used commonly as a routine part of a comprehensive geriatric assessment (Koenig,
Meador, Cohen, & Blazer, 1988). One point is assigned to each answer that indicates
depression and the cumulative score is rated on a scoring grid. The grid sets a range of
0 to 9 as "normal", 10 to 19 as "mildly depressed", and 20 to 30 as "severely depressed"
(Lesher & Berryhill, 1994). One participant scored 22/30 on the GDS, indicating severe
depression. The participant’s attending neurologist (CS) was notified about the score
on this measure. All other 27 participants had scores on the GDS that indicated they
did not suffer from severe depression. The purpose of using the GDS in our study was
to screen for individuals in the study who may be affected by depression, which could
affect their scores on other tests of cognition and language, such as the MoCA and SF36.
Participants with ALS then completed the MoCA (Nasreddine et al., 2005). The
MoCA is a screening instrument designed to detect mild cognitive dysfunction. The
MoCA has well established and robust validity and reliability psychometric properties
(Nasreddine et al., 2005). The MoCA contains tasks designed to assess attention and
concentration, executive functions, memory, language, visuoconstructional skills,
conceptual thinking, calculations, and orientation. It takes approximately 10 minutes to
administer the MoCA. The maximum possible score is 30 points; a score of 26 or above
is considered normal (Nasreddine et al., 2005). Adjustments in administration and
scoring were made in accordance with published criteria for participants with clinically
significant motor impairments (Nasreddine et al., 2005). One point was added to the
total score if the participants’ education was less than or equal to 12 years, as is
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standard in MoCA testing (Nasreddine et al., 2005). There were ten participants who
were unable to write due to physical limitations. These individuals, completed the trailmaking task of the MoCA verbally. These same individuals who were unable to write,
were unable to complete the cube drawing and clock drawing subtests of the MoCA.
These individuals could only obtain a maximum score of 26. All of the MoCA scores for
each of the 28 participants were converted into percentage scores to account for the
differences in total possible items correct (26 or 30). The MoCA was administered in
this study to identify those participants who might possess mild cognitive impairment.
Participants with ALS also completed a general health related quality of life
(HRQoL) measure called the Short Form 36 (SF-36) (Ware & Sherbourne, 1992), and
the American Speech and Hearing Society’s Quality of Communication Scale (ASHA
QCL) (Paul et al., 2004). The SF-36 is a self-administered general measure of HRQoL,
which focuses on physical and mental aspects. It consists of 36 items in eight health
domains; (1) limitations in physical activities because of health problems, (2) limitations
in social activities because of physical or emotional problems, (3) limitations in usual
role activities because of physical health problems, (4) bodily pain, (5) general mental
health (psychological distress and well-being), (6) limitations in usual role functioning
because of emotional problems, (7) vitality (energy and fatigue), and (8) general health
problems (Ware & Sherbourne, 1992). Participants record responses using a Likert
method of summated ratings. The SF-36 takes approximately 10 to 15 minutes to
complete. Scores are translated to a scale from 0 to 100, where higher scores represent
a higher (i.e., better) HRQoL. The SF-36 was chosen as a generic HRQoL measure
because of its robust use with the ALS population, and its overall strong reliability and

26

validity psychometric properties in the general population and in several different
disease groups (e.g., stroke, multiple sclerosis, and cancer). Scores on the SF-36 are
normalized such that a score of 50 becomes the average score and the norm. This
norm-based score enables comparison across more than 17,000 studies in the last 20
years (Calsyn et al., 2004). The SF-36 displays good internal consistency (>0.80 in all
dimensions except social functioning, 0.68) (Gandek et al., 2004; McCallum, 1995;
McHorney, Ware, Lu, & Sherbourne, 1994; Stevenson, 1996; Ware, Kosinski, & Keller,
1994). It possesses adequate test-retest reliability (>0.70 in all studies) (Bowling, 1995;
Hopman et al., 2004; Kagee, 2001; Sanson-Fisher & Perkins, 1998; Ware et al., 1994).
Inter-rater reliability has not been measured because it is a self-administered tool. The
SF-36 also is a very valid instrument. Studies showed that it possesses adequate
discriminatory power (Kagee, 2001; Komaroff et al., 1996), good correlation with other
measures (0.19-0.69 across domains) (Beaton, Hogg-Johnson & Bombardiner, 1997;
Calsyn et al., 2004; Essink-Bot, Krabbe, Bonel, & Aaronson, 1997; Prieto, Alonson,
Ferrer, & Anto, 1997), good construct validity (>0.70) (Jenkinson, 1999; Ware et al.,
1995, 1998), and good criterion validity (>0.70) (Elliott, Renier, & Palcher, 2003; Kagee,
2001; Jenkinson, Wright & Coulter, 1994). The SF-36 also is sensitive to change,
(Jenkinson, Lawerence, McWhinnie, & Gordon, 1995; Jenkinson et al., 1997; Sharples,
Todd, Caine, & Tait, 2000), is translated into many languages and its content can be
administered cross-culturally (Perneger, Lepledge & Etter, 1999; Wagner et al., 1998).
The SF-36 has been used in previous studies designed to examine determinants of
HRQoL in individuals with ALS (Neudert, Wasner, & Borasio, 2004; Olsson Orzanne et
al., 2011; Swash, 1998). However, with only a few questions in the SF-36 that address
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communication and social interaction, the American Speech and Hearing Association’s
Quality of Communication Life Scale (ASHA QCL) was completed by participants in this
study to provide greater detail about the factors of communication and language
impairments that load onto overall QoL in individuals with ALS. The ASHA QCL
possesses adequate reliability and validity across a population of 85 individuals with the
following conditions: aphasia due to left or right-hemispheric stroke, cognitive
communication disorder due to traumatic brain injury, and dysarthria due to an acquired
progressive neurological disease such as Parkinson’s disease, Multiple Sclerosis, and
ALS (Paul et al., 2004). Although the ASHA QCL has not been widely cited in the
literature, it was chosen for this study because of its communication context. The
purpose of using the ASHA QCL was to access participant’s self-rated quality of
communication.
Lastly, ALS disease severity was measured using the ALS-Functional Rating
Scale- Revised (ALSFRS-R) (Cedarbaum et al., 1999). The ALSFRS-R is a validated
rating instrument for monitoring the progression of disability in patients with ALS. The
original ALSFRS had a disproportionate weighting toward limb and to bulbar onset vs.
respiratory dysfunction. It is now validated as a revised version of the ALSFRS-R, which
incorporates additional assessments of dyspnea, orthopnea, and the need for ventilator
support. The Revised ALSFRS (ALSFRS-R) retains similar psychometric properties of
the original scale and shows strong internal consistency and construct validity.
ALSFRS-R scores correlate significantly with quality of life as measured by the
Sickness Impact Profile, indicating that the quality of function is a strong determinant of
quality of life in ALS (Cedarbaum et al., 1999). The purpose of using the ALSFRS-R
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was to assess participant’s disease severity, which can widely vary from individual to
individual within the ALS population. Disease severity could affect scores on other
measures of HRQoL such as the SF-36.
Speech intelligibility is defined as, “the match between the intention of the
speaker and the response of the listener to the speech passaged through the
transmission system” (Kent, 1992, pp. 13). Speech intelligibility was rated by a group of
15 adult, naïve independent listeners for all participants with ALS. There are several
ways to quantify speech intelligibility using naïve listeners. The first procedure involves
using a word identification task in which the listener writes down every word that the
speaker says. The second procedure involves the use of a scaling protocol in which the
listener makes judgments about the talker’s intelligibility using a technique such as an
equal appearing interval scale or direct magnitude estimation (Kent, 1992). Scaling
procedures are an appropriate alternative to a more time-consuming, expensive, or
cumbersome procedures, such as direct magnitude estimation and direct transcription.
(Metz, Schiavetti, & Sitler, 1980). A visual analogue scale (VAS) was used to measure
speech intelligibility. The VAS scale consisted of a 10 cm line with anchors of
“Completely Intelligible” and “Completely Unintelligible” (See Appendix B). The n=15
naïve raters of participants’ speech samples were blinded to the objectives of the study
and to the nature of the participants’ diagnosis. They were, however, given the picture
of the Cookie Theft description task before listening to the speech samples. All naïve
listeners were between the ages of 18 and 57 years, with no self-reported hearing
problems. Five listeners were graduate students in the School of Occupational Therapy
at Western University. Ten listeners were friends and relatives of KF. All of the
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listerners were naïve to the nature and purpose of the study. They listened to the
speech samples in a quiet environment with a sound pressure level of 70 decibels HL to
ensure the samples were presented at a reasonable loudness level. The samples were
audio samples only and did not portray any visual description of the participants. The
samples were given in three randomized orders. Six participant samples were
duplicated to access intra-rater reliability in judging speech intelligibility. This protocol
was used successfully by Cooper et al., (2008) in her study of verbal naming among
individuals with ALS. The inter-rater reliability score was strong for speech intelligibility
across listeners (r = .850) using an interclass correlation coefficient. The intra-rater
reliability score also was strong (average r = .988) across all 15 raters using an
interclass correlation coefficient. The purpose of accessing speech intelligibility in this
study was to measure severity of dysarthria and to ensure any deficits found on
category fluency tasks are attributable to language or cognitive-communication declines
rather than to motor speech difficulties as a result of a possible mixed flaccid-spastic
dysarthria.
Data Analyses
Measures of central tendency were calculated including the mean, standard
deviation, and range for all measures of language, speech intelligibility, cognition,
depression, and quality of life. These values were calculated in order to compare scores
to normative data and to describe overall trends in the data.
Research question 1 addressed the association between language (BNT, verbal
fluency (animals), total words, total utterances, MLU, CIU, CU, and Words/CU) and
quality of communication (ASHA QCL), and the association between language (BNT,
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verbal fluency (animals), total words, total utterances, MLU, CIU, CU, and Words/CU)
and HRQoL (SF-36). Pearson’s correlations were calculated between each measure of
language and the ASHA QCL and SF-36. In statistics, the Pearson product-moment
correlation coefficient is a measure of the linear correlation (dependence) between two
variables, giving a value between +1 and −1 inclusive. It is widely used in the social,
cognitive, linguistic and neurosciences as a measure of the strength of linear
dependence between two variables. Given the normal distribution of the data in this
study, Pearson’s correlations were chosen as the appropriate measure to analyze the
relationship between the variables in the study. The alpha level was set at p < 0.05 for
all analyses. However, a multiple comparisons correction was then applied to the
significance level using a Bonferroni correction. The Bonferroni correction was applied
to each research question individually, as part of a “family wise correction error” in
which each research questions was considered a “family comparison.” The adjusted
significance level for research question one was p < 0.003, to account for the sixteen
correlations calculated in research question 1. If the p values were less than 0.05 but
did not meet the level of significance after the Bonferroni correction, they were
considered to be approaching significance.
Research question 2 addressed the association between speech intelligibility and
quality of communication, and the association between speech intelligibility and HRQoL.
A Pearson’s correlation was calculated between speech intelligibility and the ASHA
QCL, and between speech intelligibility and the SF-36. As described above, the alpha
level was set at p < 0.05 and a multiple comparisons correction was then applied to the
significance level using a Bonferroni correction. The Bonferroni correction was applied
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to the significance level for research question two separately, as part of a “family wise
correction error” in which each research question was considered a “family
comparison.” The adjusted significance level for research question 2 was p < 0.025.
Research question 3 addressed the association between speech intelligibility and
each of the language measures (BNT, verbal fluency for animals, total words, total
utterances, MLU, CIUs, CUs, and Words/CU). Pearson’s correlations were calculated
between speech intelligibility and each of the language measures scores. As noted
above, the alpha level was set at p < 0.05 and a multiple comparisons correction was
applied to the significance level using a Bonferroni correction. The Bonferroni
correction was applied to each research question individually, as part of a “family wise
correction error”, in which each research question was considered a “family
comparison.” The adjusted significance level for research question three was p < 0.006,
to account for the eight correlations made in research question 3.
Research question 4 addressed the relative contributions of the BNT, MoCA,
GDS, speech intelligibility, and the ALSFRS-R to quality of communication (ASHA QCL)
and to HRQoL (SF-36). A hierarchical direct-entry regression analyses was performed.
In hierarchical multiple regression, the predictor variables are entered in stages. In the
first stage, the predictor variables that we want to control for are entered into the
regression. In the second stage, the predictor variables whose relationship we want to
examine after the control variables are entered. A statistical test of the change in R²
from the first stage is used to evaluate the importance of the variables entered in the
second stage. The alpha level was set at p < 0.05. The first stage of the model
involved the BNT and the MoCA. The second stage added the GDS. The third stage of
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the model added speech intelligibility. In the last and fourth stage of the model, the
ALSFRS-R was added. After each model was computed, significance levels were
reported to show to relative contributions and predictive power that each variable had
when determining the criterion variable (ASHA QCL or SF-36). Once all the variables
were entered into each of the regression models, a regression equation for each
criterion variable (ASHA QCL and SF-36) was calculated. Zero-order, partial, and part
correlations among all of the measures were reported. Zero-order correlations are the
direct correlations (Pearson’s correlations). A partial correlation coefficient is another
way of expressing the unique relationship between the criterion variable (ASHA QCL or
SF-36) and a predictor variable (BNT, MoCA, GDS, speech intelligibility, and ALSFRSR). Partial correlations represent the correlation between the criterion variable and a
predictor variable after common variance with other predictors has been removed from
both the criterion variable and the predictor variable of interest. That is, after removing
variance that the criterion variable and the predictor variable have in common with other
predictors, the partial expresses the correlation between the residualized predictor and
the residualized criterion variables. A part correlation coefficient represents the
correlation between the criterion variable (ASHA QCL or SF-36) and a predictor variable
(BNT, MoCA, GDS, speech intelligibility, and ALSFRS-R) that has been residualized
with respect to all other predictor variables in the equation. After removing variance that
the predictor variable (BNT, MoCA, GDS, speech intelligibility, and ALSFRS-R) has in
common with other predictor variables (ASHA QCL or SF-36), the partial expresses the
correlation between the residualized predictor variable and the unaltered criterion
variable. The square of the partial can be interpreted as the proportion of the criterion
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variable (ASHA QCL or SF-36) variance associated uniquely with the predictor variable
(BNT, MoCA, GDS, speech intelligibility, and ALSFRS-R).
The purpose of these regression analyses was to analyze which predictor
variables added significant predictive power to the regression equation when predicting
each criterion variable (ASHA QCL or SF-36). This means that the regression analysis
was used to determine which scores on measures of language, cognition, depression,
speech intelligibility, or disease severity are able to predict scores of quality of
communication and HRQoL.
Results
The overall generalized results from the language measures, ASHA QCL
measure and SF-36 measure are reported at the beginning of this section. Each
research question is then addressed individually thereafter.
The mean, standard deviation and range for each language measure and quality
of communication life are presented in Table 2. The mean, standard deviation and
range of the SF-36 measure and each of its eight domains are presented in Table 3.
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Table 2
Language Measures and ASHA Quality of Communication Score (N=28)
Language and HRQoL Scores
Mean
SD
Range
BNT (max 30)
25.25
3.63
15-30
Verbal Fluency
95
19.88
65-142
Animals
18.50
3.76
12-25
Birds
12.85
3.00
9-20
Water creatures
12.71
4.47
5-24
Dogs
11.03
3.33
5-17
Transportation
14.07
3.99
9-24
Musical instruments
13.39
3.92
8-23
Tools
12.42
4.34
5-21
Cookie Theft description
Total words
84.57
44.37
17-186
Total utterances
11.39
4.96
5-28
MLU
7.35
2.32
3.4-13.22
Correct Information Units
56.18
28.07
23-123
Content Units
10.17
3.23
2-17
Words/Content Unit
8.83
4.62
3.5-15.54
ASHA QCL (max 85)
63.46
9.69
39-80
Note. HRQoL = Health related quality of life, BNT = Boston Naming Test, MLU = Mean
Length of Utterance, ASHA QCL = American Speech and Hearing Association’s Quality
of Communication Life Scale
Participants’ mean scores on the 30-item Boston Naming test were below normal
values. Normative data for the mean scores on the short form BNT for Caucasians
aged 55 to 64 is 29.2 +/- 1.1 SD (Jefferson et al., 2007). Nine participants’ scores on
the BNT were between -1.5 to -2.5 SD below normals, and 14 participants were greater
than -2.5 SD below normals. Participants’ average verbal fluency scores for the
category of animals also were below normal values. Normative data for Canadians for
the mean number of animals in the verbal fluency task for individuals 16 to 59 years of
age with an education level of 13 to 21 years is 21.9 +/- 5.4 SD (Tombaugh, Kozak, &
Rees, 1999). Three individuals fell greater than -1.5 SD below the normal mean score
of individuals similar to the average education of our participants. Rakowicz and
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Hodges (1998) reported mean scores for verbal fluency for all seven categories for ten
participants with motor neuron disease but no aphasia or dementia (100.1 +/- 25.25
SD). Participants in our study performed somewhat more poorly on all categories of
verbal fluency (95 +/- 19.88 SD) when compared to scores reported by Rakowicz and
Hodges (1998).
Table 3
Healthy Related Quality of Life Scores on the SF-36 for ALS Participants (N=28)
HRQoL Scores
Mean
SF-36 Total Average Score
43.06
Physical functioning
16.25
Role limitations due to
physical health problems
32.14
Role limitations due to
emotional problems
67.86
Energy/fatigue
43.03
Emotional well-being
78.14
Social functioning
62.41
Pain
63.84
General health
42.5
Note. HRQoL = Health related quality of life

SD
15.37
39.59

Range
15-60.69
0-85

39.59

0-100

35.70
22.70
14.58
30.21
29.61
19.41

0-100
0-75
28-92
0-100
0-100
5-80

Scores on the SF-36 are calibrated such that a score of 50 becomes the average
score and the norm. The overall mean score on the SF-36 for the n=28 participants in
the study was below normal (see Table 3). The most notably low average score was in
the subdomain of physical functioning where as the highest average score was in the
domain of emotional well-being, which was well above 50. Mean subdomain scores
that fell below 50 include the domains of physical functioning, role limitations due to
physical functioning, energy/fatigue, and general health. Mean subdomain scores that
were above 50 include the domains of role limitations due to emotional problems,
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emotional well-being, social functioning, and pain. There was a high level of dispersion
among the scores on the SF-36 and each of its subdomains. Scores on four
subdomains ranged from the lowest possible value of zero to the highest possible score
of 100.
Research Question 1
Research question 1 addressed the association between the language measures
and the quality of life measures. The association was examined to determine if an
impairment of language performance in ALS affects the quality of communication or
HRQoL among individuals with ALS. Pearson’s correlation coefficients were computed
between each language measure (i.e., BNT, verbal fluency for animals, total words,
total utterances, MLU, CIU, CU, and Words/CU) and the ASHA QCL and SF-36 scores.
The correlation coefficients and their p values are show in Table 4. A moderate positive
correlation was found between the ASHA QCL and language measures of verbal
fluency (animals), total utterances, and words per content unit (p < 0.10), which
approached the set significance level of p < 0.05. There were no significant correlations
between any of the language measures and the SF-36. A Bonferroni correction was
applied to the significance level for each correlation that addressed research question 1
to account for the multiple comparisons. None of the language measures were
significantly correlated after the correction was applied (i.e., p < 0.003).
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Table 4
Pearson’s Correlations Between Language and Quality of Life Measures (N=28)
Language Measure ASHA QCL p value
SF-36
p value
BNT
-.198
.311
.119
.545
Verbal Fluency
.480*
.010
.063
.749
Total Words
.230
.240
-.171
.385
Total Utterances
.354*
.064
-.062
.754
MLU
-.030
.880
-.246
.207
CIU
.122
.535
-.185
.347
CU
.007
.971
-.186
.344
Words/CU
.346*
.071
.152
.440
Note. *Correlation is significant at the 0.10 level (2-tailed).
**Correlation is significant at the 0.05 level (2-tailed).
***Correlation is significant after Bonferroni correction.
BNT = Boston Naming Test, MLU = Mean Length of Utterance,
CIUs = Correct Information Units, CUs = Content Units

Box plots were displayed using IBM Statistics SPSS Version 19 to determine if
there were any outliers in the language and HRQoL data. The box plots show the first
quartile (bottom of box) and third quartile (top of box) (i.e., the 25th and 75th
percentiles). The plots also display the median (the horizontal line in the box), the range
(excluding outliers and extreme scores), the "whiskers" or lines that extend from the box
show the range, and the outliers (a circle represents each outlier and the number next
to the outlier is the participant number). An outlier is defined as a score that is between
1.5 and 3 box lengths away from the upper or lower edge of the box (the box represents
the middle 50 percent of the scores). An extreme score (represented by an asterisk) is
defined as a score that is greater than 3 box lengths away from the upper or lower edge
of the box. Figure 1 shows that participants 6 and 22 were outliers and participant 28
was an extreme value on the BNT data. When these three participants’ BNT scores
were excluded from analyses, the correlations between the BNT and the ASHA QCL (r
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= -.243; p= .242) and between the BNT and the SF-36 remained not statistically
significant (r = .190; p = .363).
Figure 1
Box Plots of the BNT Showing Outliers

Participants 18 and 27 were the two outliers for Words/CU as shown in Figure 2.
When these cases were excluded from analyses, the correlation between Words/CU
and the ASHA QCL was r = 0.271 (p= .181). The correlation between Words/CU and
the SF-36 with the outliers excluded was r = -0.107 (p= 0.601), remaining not
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statistically significant. All of the variables for the language data were plotted using box
plots and no other measures had any outliers or extreme scores.

Figure 2
Box Plot for Words per Content Unit Showing Outliers
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Research Question 2
Research question 2 addressed the correlation between speech intelligibility and
the quality of life measures. The correlation was calculated to determine if speech
intelligibility is associated with quality of communication and HRQoL. Table 5 shows the
Pearson’s correlation coefficients and their associated p values. Mean speech
intelligibility scores ranged from 5.25 to 95.33. There were no outliers when speech
intelligibility scores were plotted using box plots.
There was a moderately positive significant correlation between speech
intelligibility and the ASHA QCL (see Table 5 below). That is, as speech intelligibility
declined scores on the ASHA QCL declined. There was no significant correlation
between speech intelligibility and the SF-36. When the p value for research question 2
was adjusted using a Bonferroni correction, the correlation between speech intelligibility
and the ASHA QCL was still significant at the corrected p value (i.e., p < 0.025).
Table 5
Pearson’s Correlations Between Speech Intelligibility Measures and Quality of Life
Measures (N=28)
Quality of
Speech
p value
SF-36
p value
Communication
Intelligibility
ASHA QCL
.522***
.004
-.138
.483
Note. *Correlation is significant at the 0.10 level (2-tailed).
**Correlation is significant at the 0.05 level (2-tailed).
***Correlation is significant after Bonferroni correction.
ASHA QCL = American Speech and Hearing Association’s Quality of Communication
Life Scale

41

Research Question 3
Research question 3 addressed the association between language performance
and speech intelligibility. Table 6 shows the Pearson’s correlation coefficient between
each language measure and the speech intelligibility score, and their associated p
values. There were positive significant correlations between verbal fluency (animals),
total words, and total utterances with speech intelligibility. Only the category of animals
was used for the verbal fluency measure to minimize multiple comparisons. Also, there
are only normative data available for the verbal fluency category of animals. There was
a strong positive significant correlation between speech intelligibility and words per CU.
That is, as speech intelligibility improved there was an increase in the number of words
per content unit. A Bonferroni correction was applied to the significance level to
account for multiple comparisons. When the Bonferroni correction was applied, none of
the correlations reached significance (i.e., p < 0.006). However, the correlation between
speech intelligibility and words/CU approached significance.
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Table 6
Pearson’s Correlations Between Language and Speech Intelligibility Measures (N=28)
Language Measure
Speech Intelligibility
p value
BNT
-.138
.485
Verbal Fluency
.354*
.065
Total Words
.355*
.064
Total Utterances
.353*
.065
MLU
.102
.605
CIU
.244
.212
CU
-.159
.420
Words/CU
.486**
.009
Note. *Correlation is significant at the 0.10 level (2-tailed).
**Correlation is significant at the 0.05 level (2-tailed).
***Correlation is significant after Bonferroni correction.
BNT = Boston Naming Test, MLU = Mean Length of Utterance,
CIU = Correct Information Units, CU = Content Units
Research Question 4
Regression Analyses
Hierarchical direct-entry regression analyses were run by calculating a series of
prediction equations to evaluate the relative contributions of cognitive or language
impairments, depression, speech intelligibility, and physical function scores to ASHA
QCL scores as a dependent variable. The first stage of the model involved the BNT
and the MoCA, yielding a non-significant prediction equation, F(2,24)= .3659, p = .527.
The second stage of the model added depression (score on the GDS). Adding the
depression score yielded a statistically significant effect for the predictive power of the
combination of variables (F(1, 23)= 7.720, p = 0.011). Speech intelligibility scores then
were added to the analyses yielding a statistically significant effect (F(1,22)= 8.168, p =
.009). Finally, physical function (i.e., ALSFRS-R) was added to the analyses. The ALSFRS values did not increase in the predictive power (F(1, 21) = .716, p = .407) beyond
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that which was found when speech intelligibility was added to the equation The final
analysis was statistically significant, F(5, 21) = 4.191, p = .008. Overall, the equation
can be written as:
ŷ= -.130 (MoCA) + .050 (BNT) -1.007(GDS) + .172 (Speech Intelligibility) - .147
(ALSFRS)+ 74.883. The zero order, partial, and part correlations between each
consecutive variable and the ASHA QCL are reported in Table 7.
Table 7
Zero-Order, Partial, and Part Correlations for MoCA, BNT, GDS, Speech Intelligibility,
ALSFRS-R and the ASHA QCL
Variable
Zero-order
Partial
Part
MoCA
-.201
-.180
-.129
BNT
-.183
.024
.017
GDS
-.494
-.567
-.486
Speech Intelligibility
.490
.537
.451
ALS-FRS
.191
-.182
-.131
Note. MoCA = Montreal Cognitive Assessment, BNT = Boston Naming
Test, GDS = Geriatric Depression Scale, ALSFRS-R = ALS- Functional
Rating Scale Revised
The relative contributions of cognitive or language impairments, depression,
speech intelligibility, and physical function to HRQoL were evaluated using a
hierarchical direct-entry regression analysis. In this evaluation, a series of prediction
equations were calculated with SF-36 as a dependent variable. The first stage of the
model included the BNT and the MOCA and resulted in a non-significant prediction
equation, F(2,24)= .358, p = .703. The second stage of the model added depression
(scores on the GDS) which produced a statistically significant increase in the predictive
power of the equation, F(1, 23)= 21.001, p < .001. Speech intelligibility then was added
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to the prediction equation, yielding no statistically significant change, F(1,22)= .698, p =
.412. Finally, physical function (ALSFRS-R) was added, which did not produce an
incremental prediction beyond what was found when depression was added to the
equation, F(1, 21) = .236, p = .632. This final equation was statistically significant, F(5,
21) = 4.433, p = .007, and can be written as: ŷ= .036 (MoCA) + .908 (BNT) -2.234
(GDS) -.090 (Speech Intelligibility) + .135 (ALSFRS-R) + 34.327. The zero order, partial,
and part correlations between each consecutive variable and the SF-36 are reported in
Table 8.
Table 8
Zero-order, Partial, and Part Correlations for MoCA, BNT, GDS, Speech Intelligibility,
ALSFRS-R and the SF-36
Variable
Zero-order
Partial
Part
MoCA
.162
.032
.022
BNT
.116
.279
.203
GDS
-.655
-.690
-.665
Speech Intelligibility
-.132
-.203
-.145
ALSFRS-R
.082
.105
.074
Note. MoCA = Montreal Cognitive Assessment, BNT =
Boston Naming Test, GDS = Geriatric Depression Scale,
ALSFRS-R = ALS-Functional Rating Scale Revised
Table 9 contains a summary of the significant research findings for the study.
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Table 9.
Summary of Significant Findings
Research Question
Significant Relationship
RQ1a. Language measures and ASHA QCL Verbal Fluency* (r = .480)
Total Utterances* (r = .354)
Words/CU* (r = .346)
RQ1b. Language measures and SF-36
NS
RQ2a. Speech Intelligibility and ASHA QCL r = .522***
RQ2b. Speech Intelligibility and SF-36
NS
RQ3. Language measures and Speech
Verbal Fluency* (r = .354)
Intelligibility
Total Words* (r = .355)
Total Utterances* (r = .353)
Words/CU** (r = .486)
RQ4a. Predictors of ASHA QCL
GDS**, Speech Intelligibility**
RQ4b. Predictors of SF-36
GDS**
Note. *. Correlation is significant at the 0.10 level (2-tailed).
**. Correlation is significant at the 0.05 level (2-tailed).
***. Correlation is significant after Bonferroni correction.
NS= not significant
CU = Content Units

Discussion
In this section, the meaning and importance of the overall findings are discussed
first. These interpretations then are followed by a discussion of the significance and
importance of the results for each research question. The section concludes with a
discussion of the strengths and limitations of the study and possible future directions.
Consistent with previous published literature (Abrahams et al., 2004; Abrahams,
Leigh, & Goldstein, 2005; Mantovan et al., 2003; Racowicz & Hodges, 1998; South et
al., 2011; Strong et al., 1999). the participants with ALS in this study exhibited word
retrieval problems on the confrontation-naming task (BNT) as well as on the category
fluency tasks (verbal fluency) Overall mean scores on the BNT were significantly below
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normative data. Although there are no normative data for six of the seven categories of
verbal fluency used in this study, normative data for the category of animals suggests
that a very small portion of the participants were slightly below normative values. In
comparison to total scores on the same seven of the categories of verbal fluency
studied by Rakowicz and Hodges (1998), the participants with ALS in this study were
below average on total number of exemplars compared to the ALS sample of their
study. These results are consistent with previous literature that shows that individuals
with ALS without CI or FTD have language impairments such as word retrieval
problems (Abrahams et al., 2004, 2005; Mantovan et al., 2003; Racowicz & Hodges,
1998; South, et al., 2011; Strong et al., 1999), difficulties in both category and letter
verbal fluency tasks (Abrahams et al., 2000; Hanagasi et al., 2002; Strong et al., 1999),
and problems in confrontation naming (Abrahams et al., 2004; Hanagasi et al., 2004;
Mantovan et al., 2003; Ringholz et al., 2005; Strong et al., 1999). These findings mean
this study adequately determined whether these language impairments, in the absence
of CI or FTD, had the potential to affect participants’ quality of communication and
HRQoL.
A cutoff score of 26 out of 30 on the MoCA indicates cognitive impairment
(Nasreddine et al., 2005). Ten participants with ALS in this study were unable to write
and therefore could not complete the cube drawing and clock drawing portions of the
MoCA. MoCA scores for these ten participants were converted to percentages. A
value below 86.67% was considered a mild cognitive impairment. Twelve of the 28
participants exhibited a mild cognitive impairment using this threshold. Such a finding is
similar to previous ALS population-based studies that showed 47% of individuals with
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ALS had no cognitive impairment whereas the remaining 53% showed some sort of
cognitive impairment, including executive dysfunction (21%), non-executive dysfunction
such as language or memory impairments (14%), comorbid FTD (14%), comorbid AD
(2%), and others with limited categorization (2%) (Phukan et al., 2012). A cognitive
impairment (CI) in the absence of FTD also is common in individuals with ALS.
Although participants with ALS and CI were not excluded from this study, a mild
cognitive impairment (MCI) can contribute to poorer performances on tests of language.
For example, studies show that persons with MCI exhibit language deficits including
verbal fluency, especially category fluency, confrontation naming, as well as language
comprehension (Ritchie, Artero, & Touchon, 2001), accuracy in syntactic reasoning
(Collie, Maruff, & Currie, 2002), and naming a rhyming word (Dwolatzky et al., 2003).
Alterations in performance on a variety of other semantic tests also have been reported.
For example, problems with lexical decision making, (Taler & Jarema, 2006), semantic
categorization (Olichney et al., 2002), semantic encoding (Puregger, Wala, Deecke, &
Dal-Bianco, 2003), and semantic priming (Davie et al., 2004) have been reported in
MCI. A MCI also could affect participants’ abilities to answer the quality of
communication and HRQoL measures. For example, those with MCI exhibit problems
with episodic memory (Backman, Small, & Fratiglioni, 2001), executive function (Albert,
Moss, Tanzi, & Jones, 2001), perceptual speed (Albert et al., 2001), verbal ability
(Convit et al., 2000), visuospatial skills (Albert et al., 2001), and attention (Nielson, Lolk,
Anderson, Anderson, & Kragh-Sorenson, 1999). All of these potential impairments
could affect the abilities of participants in this study to understand the task, to read the
task correctly and to make inferences about themselves while completing the self-rated
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scales used to assess quality of communication and HRQoL. Impairments to cognitivecommunication also could affect quality of communication and HRQoL scores. For
example, it may not strictly be a language impairment that affects participant’s everyday
communication but an overall cognitive impairment that affects their ability to have
meaningful communication. Taylor et al. (2012) found that executive dysfunction and
language dysfunction commonly occur together in ALS. However, separate impairments
in either executive dysfunction or in language can exist in ALS. This means that
executive dysfunction in the absence of a language impairment could also affect
communication. Cognitive issues in ALS, are part of an under recognized feature of
ALS, and should assessed by clinicians, because they are prominent (e.g., 35%-50%)
in the ALS population at large.
Previous literature suggests that approximately 10% of individuals with ALS are
clinically depressed (Kurt et al., 2007, McElhiney et al., 2012, Tremblay, Monchi,
Hudon, Macoir, & Monetta, 2012) Findings of depression among the participants with
ALS in this study showed a slightly higher rate of depression using the GDS. Seven
participants with ALS were categorized as moderately depressed (score of 10 to 19).
One participant showed a severe depression (score of 22/30). A second participant
was unable to complete the GDS because of a severe evoked emotional response
relative to the nature of the questions in the GDS. McElhiney et al. (2012) reported that
depression in ALS was not associated with disease severity, and prevalence rates of
depression do not increase as disease duration increases. It is likely then that those
individuals who exhibited mild depression would continue to have these depressive
symptoms had they been followed over time. Because depression has been shown to
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affect cognition (Lichetenburg et al., 1995), the high occurrence of mild to severe
depression in this study could be associated with the high occurrence of mild cognitive
impairment (as reported by the GDS and MoCA scores, respectively). It is important for
individuals with ALS and for their attending physicians, to be aware of, to report and to
treat depressive symptoms, because depression can greatly affect cognition,
communication, and HRQoL.
The SF-36 is a norm-based measure of health related quality of life. It has a
normal score of 50. Twenty of the 28 participants with ALS in this study fell below that
threshold value, indicating an overall poorer HRQoL than the normal population. Most
notably, low scores occurred in the domains of physical functioning, role limitations due
to physical functioning, energy/fatigue, and general health. This is not unexpected due
to the clinically significant physical problems associated ALS. Similar to findings from
previous studies (i.e., scores on the ALSFRS-R, Tramonti et al., 2012), the scores of the
study participants in the domain of physical functioning on the SF-36 were low. The
highest average score was in the emotional wellbeing domain of the SF-36, meaning
that although many individuals rate their physical functioning as low, they still rate their
emotional wellbeing generally much higher. Mean scores in the subdomains of role
limitations due to emotional wellbeing, social participation, and pain were all above
normal. The importance and significance of these results is that they replicate findings
in the published literature that shows physical functioning is not the main determinant of
overall HRQoL in ALS (Chio et al., 2004; Lulé et al.,, 2008; Nygren & Askmark, 2006;
Robbins et al., 2001). More importantly, the findings of this study show that other factors
affect HRQoL, such communication impairments and social relationships. The
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significance of the finding that communication relates to HRQoL in ALS is that
communication should be optimized in order to optimize HRQoL in ALS.
The ASHA QCL scores were quite variable among the study participants with
ALS. Several study participants exhibited a high self-rated quality of communication
whereas others rated their quality of communication quite low. Although no normative
data are available on the ASHA QCL to compare participants’ scores to that of a larger
normal population, overall scores on the ASHA QCL are quite low, indicating a poor
quality of communication in participants with ALS. This finding is important in that is
shows that both speech and language impairments are contributing to the overall low
quality of communication scores, given the wide range of speech intelligibility and
language scores across participants. Participants did complete question 18 of the
ASHA QCL, which asked them to rate their overall QoL on a 5-point likert scale.
However, there was no relationship between question 18 on the ASHA QCL and the
ALSFRS-R. This means that when participants with ALS gave a global rating of their
overall QoL, it was not associated with their level of physical functioning. This finding is
significant because it indicates that other factors, such as communication and social
relationships, are contributing to overall QoL.
Although the ALSFRS-R is a psychometrically sound tool to determine physical
functional capacity and survival times in ALS, there are no published scores that are
considered normal in the widely variable and individualized progression of ALS
(Castrillo-Viguera, Grasso, Simpson, Shefner, & Cudkowicz, 2010). It is important to
distinguish that length of disease duration in ALS does not indicate disease severity.
Although the length of disease duration for each participant in this study was not
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reported, the severity of disease, as determined by the ALSFRS-R, was reported. Many
of the participants in the current study were highly functional with high scores (as
established by scores of 40 or more) on the ALSFRS-R (score of 45/48), whereas
others were extremely low (score of 13/48).
Overall, the preliminary results are in keeping with previous published studies in
ALS as reported above. The study sample was representative of the ALS population at
large in terms of prevalence of language impairments, depression, and MCI. The
physical limitations represented in the sample also are similar to the general ALS
population, which varies greatly in the site of onset, symptoms of disease, severity of
disease, and disease duration. The study sample is a meaningful group to address the
proposed research questions.
Research Question 1
Research question 1 addressed the associations between language and quality
of communication, and between language and HRQoL. The question was posed to
determine if an impairment of language performance in participants with ALS affects
their quality of communication or their HRQoL.
Scores on the BNT did not correlate significantly with scores on the ASHA QCL.
However, other measures used in this study to access language performance correlated
moderately well with the ASHA QCL and, in some instances, approached significance.
Verbal fluency for the category of animals, as well as total utterances and words per
content unit on the Cookie Theft description task (BDAE), showed a moderate
correlation that approached significance. This means that, although many individuals

52

with ALS have difficulty on confrontation naming tasks (Abrahams et al., 2004;
Hanagasi et al., 2004; Mantovan et al., 2003; Ringholz et al., 2005; Strong et al., 1999),
as was the case among the participants in this study, these difficulties may not be
associated with participants’ self-rated quality of communication. This also could be
explained by the questions addressed in the ASHA QCL, which do not include
questions about language or cognitive performance but which focus more on
communication participation, social engagement, and speech intelligibility. Moreover,
individuals with ALS may not be aware that language and cognitive problems occur in
ALS. Language deficits in ALS have been under recognized for many reasons.
Prominent dysarthria provides a plausible explanation for abnormalities in language
production. Simple picture naming tasks, such as that of the BNT, are not
representative of deficits beyond the single word level. Many of the tasks used to
assess language and cognition in this study were developed to be used on persons with
intact motor functions, meaning that physical functioning also could have affected
participants’ performance on many of the tasks, although this is only a remote possibility
given the nature of the assessment tasks.
The word generation task (i.e., verbal fluency task for animals) was mildly
correlated to the ASHA QCL, meaning that the more words the participant was able to
generate, the better the participant rated their quality of communication. It is well
documented that individuals with ALS also are impaired in letter fluency tasks
(Abrahams et al., 2004), which should be addressed in future studies of executive
functioning and HRQoL. Interestingly, there was a positive correlation between words
per content unit and the ASHA QCL. Words per content unit is considered a measure
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of content efficiency in discourse tasks. The more words per content unit, the less
efficient participants were in describing the picture. This means that they used more
words to convey the content of the picture. Total utterances, which also was correlated
positively with the ASHA QCL, is a measure of productivity in discourse. These results
suggest that individuals who are using more words and more utterances per content
unit are rating themselves higher on the ASHA QCL. Overall, measures of content
efficiency and content productivity in discourse samples are associated with quality of
communication whereas measures of content were not associated with quality of
communication. This could be due to their severity of dysarthria, which limits their
speech output. This theme is addressed in the discussion of findings for research
questions 2 and 3. The results for research question1 suggest that reduced content
efficiency during discourse could affect overall quality of communication. Although
many individuals preformed poorly on confrontation and generative naming tasks, it was
mainly the efficiency in discourse measures that were correlated to quality of
communication. The significance of these findings is that discourse performance is
more important to the quality of communication for individuals with ALS than is their
ability to recall the names of nouns in a confrontation task or on category retrieval task
(i.e., verbal fluency). Discourse can be conceptualized as “representing that level of
communicative function wherein the interaction between linguistic and cognitive abilities
is most clearly manifested, and where complexity of language is quite high” (Ulatowska,
Cannito, Hayashi, & Fleming, 1985, p. 128). The challenge of complexity of discourse
tasks in individuals with ALS could be the reason for why the association with quality of
communication is so high. More complex tasks, such as the discourse task used in this
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study may be more representative of communicative dysfunction in ALS versus that of
simple word recognition and word generation. It appears that deficits at the single word
level may not translate into important communication difficulties in individuals with ALS.
Further research into discourse performance in ALS and its association with quality of
communication should be examined, because our study showed that efficiency and
productivity measures of discourse are correlated with quality of communication. The
strategies individuals with ALS are using during discourse, as well as the relationship
between discourse output and speech intelligibility, need to be examined further. The
prominent dysarthria in some individuals with ALS offers a plausible explanation for
poor discourse performance. Future research into the relationships between speech
intelligibility and discourse performance are warranted.
There was no association between language performance and overall HRQoL
(SF-36). It is not surprising that there was no statistically significant association given
that the SF-36 is heavily weighted in the physical domain and does not address
questions about communication. Because language performance was correlated with
quality of communication life scores, language could indirectly affect HRQoL but not
through measures that are primarily focused on physical issues. Also, because a
HRQoL measure was used versus using a general QoL measure, future studies that
include QoL measures could reveal an association with language performance among
individuals with ALS.
Research Question 2
Research question 2 examined whether there is an association between speech
intelligibility and quality of communication (ASHA QCL), and between speech
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intelligibility and HRQoL (SF-36) in individuals with ALS. Findings showed that there is a
moderate statistically significant positive correlation between speech intelligibility and
the ASHA QCL. This finding is not entirely surprising given that there are multiple
questions on the ASHA QCL that address speech intelligibility issues relative to quality
of communication. Speech intelligibility was not associated with the SF-36, which again
could be due to the physical focus of the items on the SF-36 relative to health related
quality of life. For example, an individual with limb onset ALS could have very low
scores on the SF-36 due to their physical immobility issues but simultaneously could
have high speech intelligibility because their speech muscles are not as affected by the
disease. Because speech intelligibility is moderately associated with quality of
communication, it would be expected that speech intelligibility would alter global ratings
of QoL. Further research is warranted to explore the relationship between speech
intelligibility and its contributions to quality of communication and HRQoL. Alternative
methods in analyzing speech intelligibility in ALS may provide further insights into the
relationship between speech intelligibility and quality of communication. For example, a
direct transcription method of assessing speech intelligibility could lower scores of
perceived speech intelligibility and could be more highly correlated with scores of quality
of communication.
In order to improve communication quality of life among individuals with ALS,
future research should focus on speech intelligibility issues and managing symptoms of
dysarthria in individuals with ALS. Clinically, the typical main focus of speech-language
pathologists (SLP) who treat in individuals with ALS is on their speech and swallowing
concerns (Bedlack & Mitsumoto, 2012). Based on the findings from this study, SLP
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should continue to focus on helping individuals use strategies to maintain spoken
communication (i.e., discourse output beyond the single word), including voice
amplification devices and other AAC devices to optimize speech intelligibility and
therefore improve quality of communication life.
Research Question 3
Research question 3 addressed whether there is an association between
language performance and speech intelligibility in individuals with ALS. An emerging
association (i.e., approaching statistical significance) was found between language
performance on verbal fluency for animals, total words, and utterances on the Cookie
Theft picture description task and speech intelligibility. This is an important finding,
because it means that performances on these language tasks could have been affected
by participants’ motor speech impairments. More importantly, there was a moderate but
significant positive correlation between speech intelligibility and words per content unit
on the Cookie Theft picture description task. These results suggest that those
individuals with ALS who have poor speech intelligibility are likely to exhibit reduced
verbal output and reduced content productivity on a picture descriptions task. Picture
description tasks often are used to elicit a language sample of adults with speech,
language and cognitive-communication disorders. Based on this finding, it is important
for SLP to optimize speech intelligibility as well as language and cognitive performances
in order to optimize discourse production. Individuals with ALS and its associated mixed
dysarthria are likely to say few words overall and to use few content words to convey
information (i.e., few content units). These individuals could be using strategies to limit
the number of words they use to convey information, such as leaving out propositions
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and conjunctions (Hammen & Yorkston, 1996). Based on the findings for research
question 3, SLP, must focus on optimizing speech intelligibility in individuals with ALS
while being conscious of the effects of speech intelligibility on language and discourse
productions measures. Future studies should explore this possibility among individuals
with moderate to severe dysarthria associated with ALS. Moreover, future studies could
explore this relationship via written modalities to parcel out the effects of poor motor
speech performance.
Research Question 4
Research question 4 addressed the relative contributions of the BNT, MoCA,
GDS, speech intelligibility, and the ALSFRS-R on the quality of communication (ASHA
QCL) and on a general measure of HRQoL (i.e., SF-36). The purpose of research
question 4 was to determine which variables were able to predict scores on the ASHA
QCL and SF-36. In the hierarchical direct-entry regression model used to predict the
ASHA QCL scores, speech intelligibility added the most predictive power to the
prediction equation. This means that speech intelligibility has a significant influence on
how individuals with ALS rate their quality of communication. This finding was expected
due to the number of questions on the ASHA QCL that address issues related to
speech intelligibility. The GDS also added significantly to the equation, indicating that
depression may be a factor in quality of communication among individuals with ALS.
Many of the 18 items in the ASHA QCL, however, contain items related to social
participation (e.g., I like to talk with people, I get out of the house and do things like
dinners, parties, and shows, etc.). Social participation is affected by depression (Kivela,
1994). Consequently, the presence of depression among individuals with ALS will yield
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lower scores on the ASHA QCL. Given that there were seven participants in the study
with mild depression, as measured by scores on the GDS, it is not surprising that
depression loaded onto the regression equation that predicted HRQoL. It was
established at the outset of the study that we would not use depression as an exclusion
criteria, because many individuals would have scores indicating the presence based on
the nature of their disease and the literature in ALS noting the prevalence of depression
(Kurt et al.,, 2007; McElhiney et al., 2012). Depression was used instead as a predictor
variable to determine its contributions to quality of communication and HRQoL.
Physical functioning in ALS, measured by items on the ALSFRS-R, was not a
significant contribution to the AHSA QCL equation. This lack of effect on the quality of
communication was not surprising, because the ASHA QCL does not contain items that
address physical functioning. Although the cognitive and language scores did not
contribute the most to the regression equation, it is most interesting that the MoCA,
BNT, GDS, and speech intelligibility scores can explain 40% of the variance in the data.
The importance of this finding is that quality of communication is not determined by one
factor alone. Many factors, such as cognition, language performance, dysarthria and
fatigue, can affect communication in ALS. Quality of communication in ALS is complex,
with many different factors playing a role including, overall cognitive performance,
naming, mood/emotional valence, and speech clarity.
In the hierarchical direct-entry regression model used for the SF-36, the only
variable that added a significant predictive power to the equation was the GDS. This
means that individuals with ALS who experience depression could have greatly lowered
HRQoL. Goldstein et al. (2002) showed that depression was not significantly correlated
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with overall QoL (SEIQoL-DW scores). Interestingly, the ALSFRS-R scores did not add
any incremental increase to the significance of the equation, indicating that physical
functioning is not associated with overall health related quality of life. This is interesting
considering the physical nature of the SF-36 and the low scores that were shown in the
physical domains of the SF-36 by study participants. These results are in contrast to
previous studies by Robbins et al. (2001), in which the authors used the ALS-specific
HRQoL scale (SIP/ALS-19) to measure HRQoL in ALS. The SIP/ALS-19 contains items
that are primarily based on physical function. Robbin et al. (2001) found that SIP/ALS19 scores decline in parallel with scores on the ALSFRS-R. Tramonti et al. (2012) also
found an overlap in the domain of physical functioning when comparing scores on the
physical functioning subscale of the SF-36 and the ALSFRS-R. Based on the findings
from this study, individuals with ALS, their family members, their caregivers, and their
medical and health care clinicians should be aware of the profound impacts that
depression can have in ALS. The findings from this study show that almost 45% of the
variance (adjusted R square) can be explained by scores from the BNT, the MoCA, and
the GDS when predicting the SF-36. This finding shows the overall significance that
cognition, language, and depression have on HRQoL in individuals with ALS. Clinicians
should be prepared to acknowledge depressive symptoms in individuals with ALS,
which can affect HRQoL more than physical symptoms alone.
Strengths and Limitations
Participants. One strength of the study was that the n=28 participants recruited
were a representative sample of the ALS population at large, as the demographics of
the sample compares favourably with larger, epidemiological studies of persons with
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ALS (Beghi et al., 2006; Phukan et al., 2012). For those participants with ALS who
were interested in participating but were no longer attending University Hospital due to
fatigue and accessibility issues, the study was completed in their homes. Some
individuals with ALS who declined to participate did so because of significantly impaired
speech intelligibility (n=2), whereas others who were anarthric were not contacted (n=3).
This is a limitation of the study, because the sample might be considered biased
towards individuals who had less severe dysarthria than the ALS population at large.
Participants who had PCO2 levels greater than 70 mmHg also were excluded, which
could have excluded individuals who had respiration issues or respiratory onset ALS.
This means that the sample could be biased towards those who were not experiencing
severe bulbar and respiratory limitations. However, the respiratory threshold criteria
eliminated those persons with ALS who could likely suffer cognitive impairment as a
result of respiratory insufficiency (Kim et al., 2007).
Participant 3 had a GDS score of 22 out of a possible 30, indicating severe
depression. Seven other participants scored between 10 to 19 out of 30 indicating mild
depression. One participant was unable to complete the GDS because of a severe
emotional reaction to the testing. The prevalence of depression in this study was
slightly higher than the prevalence of depression in the ALS population at large (Kurt et
al., 2007; McElhiney et al., 2012), meaning that depression in this study could be
affecting cognitive status. This is a limitation because the prevalence of depression in
this study could account for low cognitive performance, low self-rated quality of
communication, and low HRQoL scores.
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Ten participants were unable to write and therefore were unable to complete the
cube drawing and clock drawing portion of the MoCA. Their trail-making subtest on the
MoCA was completed verbally (i.e., they described the sequence of connecting the
letters and numbers). The MoCA scores for these participants were scored out of 26
and all scores were converted to a percentage score. The individuals who were unable
to complete these parts of the MoCA could have an overestimation of cognitive
performance. A score greater than or equal to 26 on the MoCA is considered normal.
Even when correcting for those scored out of 26, twelve participants fell below normal
(<86.66 %) indicating mild cognitive impairment in some individuals. Three individuals
fell below a 70% score on the MoCA, indicating a somewhat severe cognitive
impairment. The presence of cognitive impairment in many of the participants could
have hindered their ability to answer questionnaires such as the SF-36 and ASHA QCL,
which requires language skills, attention, and self monitoring, among other cognitive
abilities to complete.
Procedure. One weakness of the procedure used in the study was the timing
during the day when testing took place. A few participants completed the study during
late afternoon sessions after already completing a full clinic visit in the Motor Neuron
Disease Clinic. This is a limitation because these participants may have been mentally
and physically fatigued, which could have affected their performance on many of the
cognitive and language tasks. However, all participants but one agreed to complete the
data collection after being asked if they wanted to postpone to another time period.
Overall, the procedure was carried out in a consistent order, in a timely manner (1 to 1.5
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hours) and in a comfortable environment to minimize the effects of fatigue. Rest periods
were offered to all participants.
The duration of disease onset and site of disease onset were not reported in this
study, which proved to be a limitation. Further analysis using these two factors could
have shown some interesting results. For example, those individuals who have had
time to come to terms with their prognosis may have had lower scores of depression
and conversely, those individuals who have been living with the disease for longer may
have poorer HRQoL. Because these data were not collected, speculations about
possible relationships among time post onset, disease severity, and HRQoL cannot be
made at this time. Also, speech intelligibility, a bulbar feature of the disease, was
assessed. This does not necessarily mean these individuals had bulbar onset ALS.
Also, those individuals who did not experience bulbar symptoms but had low respiratory
support could also have had poor speech intelligibility due to volume issues. Future
studies separating participants into groups based on time post onset, severity, site and
type of disease onset (upper vs lower limb; bulbar vs. nonbulbar) may provide useful
results, as ALS is such a variable disease in its onset and progression. Perhaps
individuals with different sites of disease onset may have differing views on quality of
communication and HRQoL. For example, an individual who has lost the physical
ability to speak may place more importance on speech intelligibility when rating their
quality of communication, whereas an individual who has no signs of dysarthria may
place a greater importance on word findings difficulties when rating their quality of
communication. Moreover, individuals with limb onset ALS could rate their HRQoL on
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the SF-36 as lower due to its number of questions regarding walking, climbing, lifting,
bending, etc. Future studies should take all of these considerations into account.
Materials and Methods. The ASHA QCL does not contain questions that
specifically address language and cognitive problems relative to communication
problems. All questions address speech issues and communication-related
participation issues (e.g. “I get out of the house and do things such as movies, dinners,
and shows” or “I like talking with people”). It is not surprising that many of the language
measures did not significantly correlate to the ASHA QCL, because they are not
conceptually linked in any way. Although an emphasis was placed on the
communication context of the test before administration, it is likely that many
participants took into account their physical limitations when answering specific
questions such as, “I meet the communication needs of my job or school,” “I get out of
the house and do things,” or “I have household responsibilities.” Future development of
a quality of communication life questionnaire, that incorporates all aspects of
communication (i.e., speech, voice, resonance, articulation, language, cognition, etc.)
that are affected in individuals with ALS would be prudent.
The HRQoL measure (i.e., SF-36) is weighted heavily with physical domain
questions (e.g., “Does your health limit activities such as vigorous activities, moderate
activities, lifting or carrying groceries, climbing stairs, etc.?”). Although it is an excellent
tool to access health related quality of life, the study did not include a tool to reflect
overall QoL. A tool that accessed domains such as spiritual factors, socioeconomic
factors, and social support, which have been shown to be important factors in QoL for
individuals with ALS (Murphy, Albert, Weber, Del Bene, & Rowland, 2000; Simmons et
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al., 2000), may have been more appropriate. Many participants with ALS reported that
they were unsure about how to define the term “sick” while completing the
questionnaire. Although those participants who asked were told to define “sick” in any
way in which they felt the term was significant to them, some considered their disease a
sickness while others considered sickness within the same context as a cold or a flu
type illness. Although previous studies indicated that there was no relationship between
overall QoL and disease duration or site onset, HRQoL may have been related to
disease duration and site of onset, which was not captured in this study.
Data Analyses. Pearson’s correlation coefficients make two assumptions. The
first assumption is that the variables are bivariately normally distributed. The second
assumption is that the cases represent a random sample from the population and the
scores on these variables for one case are independent of scores on these variables for
other cases (Salkind, 2011). The participants of the study do not represent a random
sample of the ALS population (i.e., they are a convenience sample). However, scores
on each of the measures are independent of one another, Pearson’s correlations were
an appropriate statistical measure to analyze the relationships among variables.
However, because each research question had multiple comparisons, Bonferroni
corrections were applied to the significance level for each research question. The alpha
level for each research question was significantly lowered using the correction and thus,
may have been too restrictive.
The regression model used in the data analysis included five predictor variables.
A rule of thumb to consider when doing regression analysis is to include ten participants
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per independent variable in the regression model. Thus, the regression model used in
this study was not heavily powered by the sample size.
Future Directions
Research. It may be the case that individuals living with ALS and their caregivers
are naïve to the fact that language and cognitive issues exist in ALS. The relatively
recent discovery that language and cognitive impairments do occur in ALS may not be
well known among persons with ALS or their caregivers. Future studies should explore
whether individuals with ALS and their family caregivers are aware of the potential
language and cognitive deficits in ALS, whether they are experiencing any language or
cognitive deficits throughout their disease progression, and what associations, if any,
exist between language and cognition and HRQoL. Future analyses also should
address the determinants of caregivers of individuals with ALS HRQoL, which has been
shown to decrease as their loved ones physical functioning decreases (Roach et al.,
2009). It is known that the presence of neurobehavioural symptoms associated with
ALS-FTD correlates significantly with lower caregivers’ QoL, higher caregiver
depression, and higher caregiver burden (Chio et al., 2010). These correlations can
have profound impacts on caregivers’ emotional status (Chio, et al., 2010). However,
the effects that language impairments in individuals with ALS without ALS-FTD has on
caregivers’ HRQoL remains to be explored. Future study of the determinants of HRQoL
in indivuduals who are caregivers of persons with ALS is warranted.
Further analysis into the relationship between dysarthria and discourse should be
examined in ALS as well. Dysarthria could be masking potential affects of language
impairments in ALS, and the relationship between these two parameters needs to be
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addressed fully. A study, that examines the discourse sample of individuals with ALS
without CI versus other progressive degenerative neurological diseases that affect
speech intelligibility without any language or cognitive deficits would provide insight into
the strategies individuals with dysarthria use during discourse. Also, a more
comprehensive analysis of the discourse samples in this study is warranted, (e.g.
examining revisions, reformulations, and self-corrected utterances in the discourse
samples which have been shown to be decreased in ALS).
The MoCA may not be an adequate tool to screen cognition in ALS because of its
physical requirements. The cognitive status of individuals with ALS who are unable to
complete the cube drawing and clock drawing proportion of the MoCA might yield
scores that underestimate the severity of their cognitive impairments. The development
of a cognitive screening tool that is specific to ALS is a necessity for future studies of
cognition in ALS. Work by Abrahams, and colleagues and by Bak and colleagues
showcased at the recent 4th International Research Workshop on ALS held in London
ON (June 2013) indicates that screening measures soon will be published.
A quality of life scale that is specific to ALS has been developed, called the
ALSAQ-40 (Jenkinson et al.,1999). This scale does not include questions that address
aspects of communication, including language or cognitive-communication difficulties.
Future scales used to assess quality of life in ALS need to include questions about
communication, and less emphasis should be given to the physical domain of quality of
life.
Currently, the quality of communication life scales available to researchers and
clinicians do not address all aspects of the communication difficulties experienced by
67

individuals with ALS. The ASHA QCL used in this study did address an individual’s
ability to participate in social communication but neglects participants’ abilities to use
language effectively. Questions related to the quality of communication should be
included in future QoL measures, including speech difficulties in ALS and discourse
performance (e.g., efficiency and productivity measures). There is a definite need to
develop quality of communication measures that include items related to word finding
difficulties and discourse production.
This study used a cross sectional design. Future longitudinal studies are needed
to address the changes of quality in communication and HRQoL over the progression of
the disease. To assess changes over time, alternate versions of the language test that
are psychometrically equivalent but have different content will be needed to ensure
there is no learning affect across the testing periods. The quality of communication
scale and HRQoL scale also must be sensitive to change. It is prudent to measure the
changes in quality of communication and HRQoL, because ALS is such a rapidly
progressing disease.
Clinical. Difficulties with speech and swallowing occur commonly in individuals
with ALS and often are the primary focus of care by SLP. However, language and
cognitive communication issues also need to be a concern for SLP when assessing and
treating individuals with ALS, especially within the context of health related quality of
life. Moreover, SLP need to be concerned with the presence and effects of depression
on communication related quality of life, since results from this study showed that
depression can predict both poor quality of communication and HRQoL. SLP need to be
aware of not only the physical limitations the disease places on individuals but also how
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depression and cognition impairments may affect communication related quality of life
of individuals with ALS and, potentially, of their caregivers. Counseling individuals with
ALS, and their family members with respect to declines in all aspects of communication
and offering supportive speech, language, and communication strategies and coping
skills relative to HRQoL may prove to be very beneficial.
Summary and Conclusions
The results from this study indicate that individuals with ALS exhibit language and
cognitive impairments as well as speech intelligibility issues that affect their quality of
communication and HRQoL. Physical functioning is not a main determinant of HRQoL in
ALS. Depression was the main predictor for low HRQoL. Futhermore, speech
intelligibility is highly associated with quality of communication. Further studies should
include a larger sample size, a more extensive battery of tests used to assess
language, as well as a more detailed analysis of the relationship between discourse in
ALS and HRQoL. These studies should also use more well-developed tests of quality
of communication, screens of cognition, and HRQoL that are specific to ALS and more
appropriate for the ALS population.
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Study Title: “Language Contributions to Amyotrophic Lateral Sclerosis”
Study Investigators:
J.B. Orange, PhD
Professor and Director
School of Communication Sciences and Disorders
Western University
Katie M. Findlater
Masters Candidate, Health and Rehabilitation Sciences
Speech and Language Science Field
Western University
Christen Shoesmith
MD, FRCPC, Neurologist
Clinical Neurosciences
London Health Sciences Center, University Hospital

As a person diagnosed with amyotrophic lateral sclerosis (ALS), you are being
invited to take part in a research study conducted through Western University to
develop of a better understanding of the relationship between language and cognitivecommunication deficits and health related quality of life in amyotrophic lateral sclerosis.
The purpose of this letter is to provide you with information required for you to make an
informed decision regarding participation in this research. Our study will include twentyeight participants who also attend the Motor Neuron Disease Clinic at London Health
Sciences Centre with ALS. It is important for you to be aware of why this study is being
conducted and what it will involve. Please take the time to read this letter carefully.
Please feel free to ask any questions if any part of the explanation of our study is
unclear.
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If you agree to participate in our study, data will be collected at London Health
Sciences Centre, University Hospital, in London, Ontario. You will be compensated $20
for parking expenses, light refreshments, and for your participation.
You will be asked to complete a short hearing test to see how well you can hear
in both ears. This task will take approximately 5 minutes. Then you will be asked to
complete tasks to assess your thinking and your communicating skills. The tasks are
designed to assess your thinking; that is your ability to plan, to organize, to concentrate,
to make decisions, and to use and to understand language, etc.). In total, these tasks
will take approximately 90 to 120 minutes. You will be asked to complete these tasks
using a pen and paper. In the first task, you will be asked to complete 30 Yes-No
questions regarding your mood and assess how happy or depressed you feel. This will
take approximately 20 minutes to complete. Then you will be asked to name thirty black
and white drawings of objects. This task will take approximately 20 minutes. Next you
will be given a category (e.g. animals) and asked to name as many items as you can
think of that belong to that category. There will be seven categories for you to name
examples. This task will take about 25 minutes. You will then be asked to complete two
surveys. The first will ask you about your general health right now, including your
emotional health, physical health, and psychological state. The second will ask you
about how well you think you communicate. The surveys will take about 30 minutes to
complete. You will receive breaks every hour or at any time that you wish during the
time it takes you to complete these tasks.
Participants Initials:____
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Your spoken responses in the sessions will be video recorded and typed-up. Your
name will not appear on the transcripts. Instead a pseudonym will be used.

All

information collected for the study will be kept confidential. If the results of the study are
published, your name will not be used and no information that discloses you identity will
be released or published without your consent or disclosure.

Representatives of

Western University Health Sciences Research Ethics Board may require access to your
study-related records or may follow up with you to monitor the conduct of the study.
There are no known risks associated with the study beyond the discomfort that may
arise when one reflects on one’s own life situation. All tests will be given to you by
trained personnel in a supportive, quiet, and comfortable environment in order to ease
any potential discomfort from reflecting on your life situation. You will be allowed to take
breaks upon request if needed to ease any emotional distress. You will also be video
recorded. All video recording equipment will be placed in a way to reduce any
discomfort you may have.
You may not get a personal benefit from participating in this study but your
participation will advance the knowledge and care of individuals with ALS at large. By
taking part in this study, you will be providing information that may help to identify the
types of support services that individuals with ALS require in the aim of improving ALS
care. Participation in this study is voluntary. You may refuse to participate, refuse to
answer any questions or withdraw from the study at any time. If you are participating in
Participants Initials:____
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another study at this time, please inform the student researcher asking you questions
right away to determine if it is appropriate for you to participate in this study.

If you have any questions about this study please contact Dr. J. B. Orange,
Associate Professor, Western University.

If you have any questions about the conduct of this study or your rights as a
research subject you may contact Dr. David Hill, Scientific Director, Lawson Health
Research Institute.

This letter is yours to keep. Please be aware that none of you legal rights are
being waived by signing this consent form. If you agree to participate in this study,
please sign the consent form on the next page.

Participant Initials:___
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Consent Forms
Language Contributions to Health Related Quality of Life
in Amyotrophic Lateral Sclerosis
I have read the Letter of Information, have had the nature of the study explained
to me and I agree to participate in the research project entitled, “Language
Contributions to Health Related Quality of Life in Amyotrophic Lateral Sclerosis”. All
questions have been answered to my satisfaction.
Participant (Print Name)
_________________________________
Signature of Participate

Date

_______________________________

____________________________

Individual Obtaining Consent (Print Name)
________________________________
Signature of Individual Obtaining Consent

Date

___________________________________

___________________________________

Participant’s Initials: ____
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Appendix B
Assessment of Speech Intelligibility
ALS and Health Related Quality of Life Study
Katie Findlater and Professor JB Orange
Randomized List: ____
Listener’s Name: ________________ Age: ____ Date: __________________
Self-Reported Hearing Issues: _____ Do you wear hearing aids? Y / N
Instructions:
Please rank each of the 34 speech samples you will hear using the scale
provided below. The left side of the scale represents “Completely Intelligible” (normal)
speech, while the right side of the scale represents “Completely Unintelligible”
(profoundly disordered) speech. The scale also indicates variations in the level of
intelligibility according the following categories:
MI = Mildly Unintelligible
MO = Moderately Unintelligible
SE = Severely Unintelligible
Please mark your rating on the line using an X. You may mark the scale at any
point along its length that you believe best corresponds to your judgment of the speech
sample relative to what to you perceive to be the level of intelligibility. Please consider
the full range of possible scores.
The speech sample that you will hear will vary in length and content. However, it
is important for you to make your judgments of intelligibility independent of the length
and content across speech samples. Your judgments should be based on how well you
are able to understand the words and the speech sounds that the person is producing.
Please make your ratings independently across the samples and from the other raters.
There are no right or wrong answers. This task will take approximately 60 minutes to
complete. Thank you for your participation.

Example:

Completely

_________________________________________
MI
MO
SE

Intelligible
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Completely
Unintelligible
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